Frequencies for first 10,000 rows of pt variable in reac2008q2 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABASIA | 8 0.08 0.08 ABDOMINAL DISCOMFORT | 7 0.07 0.15 ABDOMINAL DISTENSION | 12 0.12 0.27 ABDOMINAL PAIN | 50 0.50 0.77 ABDOMINAL PAIN LOWER | 7 0.07 0.84 ABDOMINAL PAIN UPPER | 25 0.25 1.09 ABDOMINAL TENDERNESS | 2 0.02 1.11 ABNORMAL BEHAVIOUR | 24 0.24 1.35 ABNORMAL DREAMS | 15 0.15 1.50 ABNORMAL SENSATION IN EYE | 2 0.02 1.52 ABORTION | 3 0.03 1.55 ABORTION INDUCED | 4 0.04 1.59 ABORTION SPONTANEOUS | 16 0.16 1.75 ABSCESS | 7 0.07 1.82 ABSCESS JAW | 1 0.01 1.83 ACCIDENTAL EXPOSURE | 10 0.10 1.93 ACCIDENTAL OVERDOSE | 4 0.04 1.97 ACCIDENTAL POISONING | 1 0.01 1.98 ACIDOSIS | 3 0.03 2.01 ACNE | 8 0.08 2.09 ACROMEGALY | 1 0.01 2.10 ACTINIC KERATOSIS | 1 0.01 2.11 ACTINOMYCOSIS | 1 0.01 2.12 ACTIVATED PARTIAL THROMBOPLASTIN TIME.. | 4 0.04 2.16 ACTIVITIES OF DAILY LIVING IMPAIRED | 6 0.06 2.22 ACUTE ABDOMEN | 1 0.01 2.23 ACUTE FATTY LIVER OF PREGNANCY | 1 0.01 2.24 ACUTE GRAFT VERSUS HOST DISEASE | 1 0.01 2.25 ACUTE HEPATIC FAILURE | 2 0.02 2.27 ACUTE HIV INFECTION | 1 0.01 2.28 ACUTE LEFT VENTRICULAR FAILURE | 1 0.01 2.29 ACUTE MYELOID LEUKAEMIA | 1 0.01 2.30 ACUTE MYOCARDIAL INFARCTION | 5 0.05 2.35 ACUTE PSYCHOSIS | 1 0.01 2.36 ACUTE PULMONARY OEDEMA | 2 0.02 2.38 ACUTE RESPIRATORY DISTRESS SYNDROME | 11 0.11 2.49 ACUTE RESPIRATORY FAILURE | 3 0.03 2.52 ACUTE SINUSITIS | 1 0.01 2.53 ADHESION | 1 0.01 2.54 ADJUSTMENT DISORDER | 1 0.01 2.55 ADRENAL ADENOMA | 1 0.01 2.56 ADRENAL ATROPHY | 1 0.01 2.57 ADRENAL INSUFFICIENCY | 1 0.01 2.58 ADVERSE DRUG REACTION | 3 0.03 2.61 ADVERSE EVENT | 16 0.16 2.77 AFFECT LABILITY | 3 0.03 2.80 AFFECTIVE DISORDER | 2 0.02 2.82 AGEUSIA | 4 0.04 2.86 AGGRESSION | 20 0.20 3.06 AGITATION | 26 0.26 3.32 AGORAPHOBIA | 1 0.01 3.33 AGRANULOCYTOSIS | 2 0.02 3.35 AKATHISIA | 3 0.03 3.38 ALANINE AMINOTRANSFERASE | 1 0.01 3.39 ALANINE AMINOTRANSFERASE INCREASED | 40 0.40 3.79 ALCOHOL INTERACTION | 1 0.01 3.80 ALCOHOL INTOLERANCE | 1 0.01 3.81 ALCOHOL USE | 1 0.01 3.82 ALLERGIC GRANULOMATOUS ANGIITIS | 2 0.02 3.84 ALOPECIA | 14 0.14 3.98 ALPHA 1 FOETOPROTEIN AMNIOTIC FLUID I.. | 1 0.01 3.99 ALPHA-1 ANTI-TRYPSIN INCREASED | 1 0.01 4.00 ALTERED STATE OF CONSCIOUSNESS | 3 0.03 4.03 ALVEOLITIS | 1 0.01 4.04 ALVEOLITIS FIBROSING | 1 0.01 4.05 AMBLYOPIA | 1 0.01 4.06 AMENORRHOEA | 8 0.08 4.14 AMMONIA INCREASED | 1 0.01 4.15 AMNESIA | 10 0.10 4.25 AMOEBIASIS | 1 0.01 4.26 AMYOTROPHIC LATERAL SCLEROSIS | 1 0.01 4.27 ANAEMIA | 56 0.56 4.83 ANAEMIA MACROCYTIC | 2 0.02 4.85 ANAL FISSURE | 2 0.02 4.87 ANAL HAEMORRHAGE | 3 0.03 4.90 ANALGESIC ASTHMA SYNDROME | 1 0.01 4.91 ANAPHYLACTIC REACTION | 18 0.18 5.09 ANAPHYLACTIC SHOCK | 7 0.07 5.16 ANAPHYLACTOID REACTION | 10 0.10 5.26 ANGER | 20 0.20 5.46 ANGINA PECTORIS | 6 0.06 5.52 ANGIOEDEMA | 20 0.20 5.72 ANGIOPATHY | 2 0.02 5.74 ANGLE CLOSURE GLAUCOMA | 1 0.01 5.75 ANHEDONIA | 4 0.04 5.79 ANKLE FRACTURE | 1 0.01 5.80 ANKLE OPERATION | 1 0.01 5.81 ANOMALY OF EXTERNAL EAR CONGENITAL | 1 0.01 5.82 ANORECTAL DISCOMFORT | 2 0.02 5.84 ANORECTAL DISORDER | 1 0.01 5.85 ANORECTAL OPERATION | 1 0.01 5.86 ANOREXIA | 26 0.26 6.12 ANOREXIA NERVOSA | 1 0.01 6.13 ANOSMIA | 4 0.04 6.17 ANOXIA | 1 0.01 6.18 ANOXIC ENCEPHALOPATHY | 1 0.01 6.19 ANTICONVULSANT DRUG LEVEL INCREASED | 1 0.01 6.20 ANTINUCLEAR ANTIBODY POSITIVE | 3 0.03 6.23 ANTIPHOSPHOLIPID SYNDROME | 1 0.01 6.24 ANURIA | 1 0.01 6.25 ANXIETY | 70 0.70 6.95 APATHY | 2 0.02 6.97 APHASIA | 7 0.07 7.04 APHONIA | 4 0.04 7.08 APHTHOUS STOMATITIS | 1 0.01 7.09 APLASIA | 1 0.01 7.10 APLASTIC ANAEMIA | 1 0.01 7.11 APNOEA | 4 0.04 7.15 APPARENT DEATH | 1 0.01 7.16 APPENDICEAL ABSCESS | 2 0.02 7.18 APPENDICITIS | 1 0.01 7.19 APPLICATION SITE DERMATITIS | 2 0.02 7.21 APPLICATION SITE DISCOLOURATION | 1 0.01 7.22 APPLICATION SITE ERYTHEMA | 20 0.20 7.42 APPLICATION SITE EXCORIATION | 1 0.01 7.43 APPLICATION SITE HYPERSENSITIVITY | 1 0.01 7.44 APPLICATION SITE IRRITATION | 2 0.02 7.46 APPLICATION SITE OEDEMA | 1 0.01 7.47 APPLICATION SITE PAPULES | 1 0.01 7.48 APPLICATION SITE PRURITUS | 18 0.18 7.66 APPLICATION SITE RASH | 12 0.12 7.78 APPLICATION SITE REACTION | 30 0.30 8.08 APPLICATION SITE SCAR | 1 0.01 8.09 APPLICATION SITE SWELLING | 2 0.02 8.11 APPLICATION SITE URTICARIA | 2 0.02 8.13 APPLICATION SITE WARMTH | 1 0.01 8.14 ARACHNOIDITIS | 1 0.01 8.15 AREFLEXIA | 1 0.01 8.16 ARRHYTHMIA | 9 0.09 8.25 ARTERIAL OCCLUSIVE DISEASE | 2 0.02 8.27 ARTERIOGRAM CORONARY | 3 0.03 8.30 ARTERIOSCLEROSIS | 2 0.02 8.32 ARTERIOSCLEROSIS CORONARY ARTERY | 3 0.03 8.35 ARTERIOSCLEROSIS OBLITERANS | 1 0.01 8.36 ARTERIOVENOUS FISTULA ANEURYSM | 1 0.01 8.37 ARTERY DISSECTION | 1 0.01 8.38 ARTHRALGIA | 39 0.39 8.77 ARTHRITIS | 9 0.09 8.86 ARTHROPATHY | 5 0.05 8.91 ASCITES | 6 0.06 8.97 ASPARTATE AMINOTRANSFERASE INCREASED | 36 0.36 9.33 ASPERGILLOSIS | 1 0.01 9.34 ASPIRATION | 3 0.03 9.37 ASTEATOSIS | 1 0.01 9.38 ASTERIXIS | 1 0.01 9.39 ASTHENIA | 55 0.55 9.94 ASTHENOPIA | 1 0.01 9.95 ASTHMA | 17 0.17 10.12 ASTHMATIC CRISIS | 1 0.01 10.13 ATAXIA | 3 0.03 10.16 ATELECTASIS | 4 0.04 10.20 ATRIAL FIBRILLATION | 13 0.13 10.33 ATRIAL FLUTTER | 1 0.01 10.34 ATRIAL SEPTAL DEFECT | 7 0.07 10.41 ATRIAL TACHYCARDIA | 1 0.01 10.42 ATRIOVENTRICULAR BLOCK | 1 0.01 10.43 ATRIOVENTRICULAR BLOCK COMPLETE | 2 0.02 10.45 ATRIOVENTRICULAR BLOCK FIRST DEGREE | 1 0.01 10.46 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 3 0.03 10.49 ATYPICAL MYCOBACTERIAL INFECTION | 1 0.01 10.50 AUTISM | 1 0.01 10.51 AUTISM SPECTRUM DISORDER | 1 0.01 10.52 AUTOIMMUNE HEPATITIS | 1 0.01 10.53 AUTOMATIC BLADDER | 1 0.01 10.54 AUTONOMIC NEUROPATHY | 1 0.01 10.55 BACK DISORDER | 1 0.01 10.56 BACK PAIN | 27 0.27 10.83 BACTERAEMIA | 4 0.04 10.87 BACTERIAL CULTURE POSITIVE | 1 0.01 10.88 BACTERIAL INFECTION | 3 0.03 10.91 BACTERIAL SEPSIS | 2 0.02 10.93 BALANCE DISORDER | 9 0.09 11.02 BALANITIS | 1 0.01 11.03 BASAL CELL CARCINOMA | 2 0.02 11.05 BEDRIDDEN | 2 0.02 11.07 BENIGN INTRACRANIAL HYPERTENSION | 3 0.03 11.10 BENIGN OVARIAN TUMOUR | 1 0.01 11.11 BENIGN PROSTATIC HYPERPLASIA | 2 0.02 11.13 BEREAVEMENT REACTION | 1 0.01 11.14 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION | 2 0.02 11.16 BEZOAR | 1 0.01 11.17 BILE DUCT CANCER | 1 0.01 11.18 BILE DUCT STENOSIS | 1 0.01 11.19 BILIARY NEOPLASM | 1 0.01 11.20 BILIRUBIN CONJUGATED INCREASED | 1 0.01 11.21 BIOPSY BONE MARROW ABNORMAL | 1 0.01 11.22 BIOPSY SKIN ABNORMAL | 1 0.01 11.23 BIPOLAR DISORDER | 5 0.05 11.28 BIPOLAR I DISORDER | 2 0.02 11.30 BITE | 1 0.01 11.31 BLADDER CATHETERISATION | 1 0.01 11.32 BLADDER DISORDER | 4 0.04 11.36 BLADDER NEOPLASM | 1 0.01 11.37 BLADDER PROLAPSE | 1 0.01 11.38 BLADDER SPASM | 1 0.01 11.39 BLEEDING TIME PROLONGED | 1 0.01 11.40 BLIGHTED OVUM | 1 0.01 11.41 BLINDNESS | 2 0.02 11.43 BLINDNESS TRANSIENT | 2 0.02 11.45 BLINDNESS UNILATERAL | 7 0.07 11.52 BLISTER | 5 0.05 11.57 BLOOD ALBUMIN ABNORMAL | 1 0.01 11.58 BLOOD ALKALINE PHOSPHATASE ABNORMAL | 1 0.01 11.59 BLOOD ALKALINE PHOSPHATASE DECREASED | 1 0.01 11.60 BLOOD ALKALINE PHOSPHATASE INCREASED | 10 0.10 11.70 BLOOD AMYLASE INCREASED | 4 0.04 11.74 BLOOD BICARBONATE DECREASED | 1 0.01 11.75 BLOOD BILIRUBIN INCREASED | 11 0.11 11.86 BLOOD BLISTER | 1 0.01 11.87 BLOOD CALCIUM DECREASED | 1 0.01 11.88 BLOOD CALCIUM INCREASED | 1 0.01 11.89 BLOOD CHLORIDE DECREASED | 1 0.01 11.90 BLOOD CHOLESTEROL INCREASED | 19 0.19 12.09 BLOOD COUNT ABNORMAL | 2 0.02 12.11 BLOOD CREATINE INCREASED | 1 0.01 12.12 BLOOD CREATINE PHOSPHOKINASE INCREASED | 16 0.16 12.28 BLOOD CREATININE ABNORMAL | 2 0.02 12.30 BLOOD CREATININE INCREASED | 33 0.33 12.63 BLOOD CULTURE POSITIVE | 2 0.02 12.65 BLOOD DISORDER | 1 0.01 12.66 BLOOD FIBRINOGEN DECREASED | 1 0.01 12.67 BLOOD FIBRINOGEN INCREASED | 1 0.01 12.68 BLOOD GASES ABNORMAL | 1 0.01 12.69 BLOOD GLUCOSE ABNORMAL | 2 0.02 12.71 BLOOD GLUCOSE DECREASED | 11 0.11 12.82 BLOOD GLUCOSE INCREASED | 38 0.38 13.20 BLOOD GROWTH HORMONE DECREASED | 2 0.02 13.22 BLOOD IMMUNOGLOBULIN E INCREASED | 1 0.01 13.23 BLOOD LACTATE DEHYDROGENASE INCREASED | 9 0.09 13.32 BLOOD LACTIC ACID INCREASED | 1 0.01 13.33 BLOOD OSMOLARITY DECREASED | 1 0.01 13.34 BLOOD PHOSPHORUS DECREASED | 1 0.01 13.35 BLOOD POTASSIUM DECREASED | 5 0.05 13.40 BLOOD POTASSIUM INCREASED | 2 0.02 13.42 BLOOD PRESSURE | 1 0.01 13.43 BLOOD PRESSURE DECREASED | 19 0.19 13.62 BLOOD PRESSURE FLUCTUATION | 2 0.02 13.64 BLOOD PRESSURE INADEQUATELY CONTROLLED | 1 0.01 13.65 BLOOD PRESSURE INCREASED | 26 0.26 13.91 BLOOD PRESSURE ORTHOSTATIC INCREASED | 1 0.01 13.92 BLOOD PRESSURE SYSTOLIC DECREASED | 1 0.01 13.93 BLOOD PROLACTIN DECREASED | 1 0.01 13.94 BLOOD PROLACTIN INCREASED | 1 0.01 13.95 BLOOD SODIUM DECREASED | 5 0.05 14.00 BLOOD SODIUM INCREASED | 1 0.01 14.01 BLOOD TESTOSTERONE DECREASED | 1 0.01 14.02 BLOOD TESTOSTERONE INCREASED | 1 0.01 14.03 BLOOD THYROID STIMULATING HORMONE DEC.. | 1 0.01 14.04 BLOOD THYROID STIMULATING HORMONE INC.. | 1 0.01 14.05 BLOOD TRIGLYCERIDES INCREASED | 57 0.57 14.62 BLOOD UREA ABNORMAL | 1 0.01 14.63 BLOOD UREA INCREASED | 7 0.07 14.70 BLOOD URINE PRESENT | 2 0.02 14.72 BLOODY PERITONEAL EFFLUENT | 1 0.01 14.73 BODY HEIGHT DECREASED | 2 0.02 14.75 BODY TEMPERATURE DECREASED | 1 0.01 14.76 BODY TEMPERATURE INCREASED | 1 0.01 14.77 BONE DEBRIDEMENT | 1 0.01 14.78 BONE DENSITY DECREASED | 2 0.02 14.80 BONE DISORDER | 4 0.04 14.84 BONE MARROW DISORDER | 1 0.01 14.85 BONE MARROW FAILURE | 7 0.07 14.92 BONE MARROW TRANSPLANT | 1 0.01 14.93 BONE PAIN | 8 0.08 15.01 BOWEL MOVEMENT IRREGULARITY | 1 0.01 15.02 BOWEN'S DISEASE | 1 0.01 15.03 BRADYARRHYTHMIA | 1 0.01 15.04 BRADYCARDIA | 21 0.21 15.25 BRADYPHRENIA | 1 0.01 15.26 BRAIN ABSCESS | 1 0.01 15.27 BRAIN INJURY | 1 0.01 15.28 BRAIN NEOPLASM | 1 0.01 15.29 BRAIN OEDEMA | 2 0.02 15.31 BRAIN SCAN ABNORMAL | 1 0.01 15.32 BRAIN STEM INFARCTION | 1 0.01 15.33 BREAST CALCIFICATIONS | 1 0.01 15.34 BREAST CANCER | 26 0.26 15.60 BREAST CANCER FEMALE | 4 0.04 15.64 BREAST CANCER IN SITU | 1 0.01 15.65 BREAST CANCER METASTATIC | 26 0.26 15.91 BREAST CANCER RECURRENT | 3 0.03 15.94 BREAST CYST | 1 0.01 15.95 BREAST DISCOMFORT | 1 0.01 15.96 BREAST DISORDER | 1 0.01 15.97 BREAST HYPERPLASIA | 1 0.01 15.98 BREAST MASS | 2 0.02 16.00 BREAST RECONSTRUCTION | 1 0.01 16.01 BREAST TENDERNESS | 1 0.01 16.02 BREATH ODOUR | 2 0.02 16.04 BREATH SOUNDS ABNORMAL | 1 0.01 16.05 BRONCHIAL HYPERREACTIVITY | 1 0.01 16.06 BRONCHIOLITIS | 1 0.01 16.07 BRONCHITIS | 7 0.07 16.14 BRONCHITIS BACTERIAL | 1 0.01 16.15 BRONCHOMALACIA | 1 0.01 16.16 BRONCHOPLEURAL FISTULA | 1 0.01 16.17 BRONCHOPNEUMONIA | 1 0.01 16.18 BRONCHOSPASM | 10 0.10 16.28 BRUXISM | 1 0.01 16.29 BUNDLE BRANCH BLOCK LEFT | 1 0.01 16.30 BUNDLE BRANCH BLOCK RIGHT | 2 0.02 16.32 BURNING SENSATION | 9 0.09 16.41 BURNS SECOND DEGREE | 1 0.01 16.42 BURSITIS | 1 0.01 16.43 C-REACTIVE PROTEIN INCREASED | 7 0.07 16.50 CAECITIS | 1 0.01 16.51 CALCIFICATION OF MUSCLE | 1 0.01 16.52 CALCINOSIS | 2 0.02 16.54 CALCULUS URETERIC | 2 0.02 16.56 CANDIDA PNEUMONIA | 1 0.01 16.57 CANDIDIASIS | 2 0.02 16.59 CARBON MONOXIDE POISONING | 1 0.01 16.60 CARCINOEMBRYONIC ANTIGEN INCREASED | 1 0.01 16.61 CARDIAC ARREST | 15 0.15 16.76 CARDIAC DEATH | 1 0.01 16.77 CARDIAC DISORDER | 11 0.11 16.88 CARDIAC FAILURE | 17 0.17 17.05 CARDIAC FAILURE CONGESTIVE | 19 0.19 17.24 CARDIAC HYPERTROPHY | 1 0.01 17.25 CARDIAC MURMUR | 2 0.02 17.27 CARDIAC VENTRICULAR DISORDER | 1 0.01 17.28 CARDIO-RESPIRATORY ARREST | 7 0.07 17.35 CARDIOGENIC SHOCK | 2 0.02 17.37 CARDIOMEGALY | 5 0.05 17.42 CARDIOMYOPATHY | 5 0.05 17.47 CARDIOMYOPATHY ACUTE | 1 0.01 17.48 CARDIOSPASM | 1 0.01 17.49 CARDIOVASCULAR DISORDER | 1 0.01 17.50 CARDIOVASCULAR INSUFFICIENCY | 1 0.01 17.51 CARDITIS | 1 0.01 17.52 CAROTID ARTERY STENOSIS | 1 0.01 17.53 CARPAL TUNNEL SYNDROME | 4 0.04 17.57 CASTLEMAN'S DISEASE | 1 0.01 17.58 CATARACT | 9 0.09 17.67 CATARACT NUCLEAR | 1 0.01 17.68 CATARACT OPERATION | 1 0.01 17.69 CATARACT SUBCAPSULAR | 1 0.01 17.70 CATATONIA | 1 0.01 17.71 CATHETER RELATED INFECTION | 2 0.02 17.73 CATHETER SEPSIS | 1 0.01 17.74 CATHETER SITE INFECTION | 1 0.01 17.75 CAUSTIC INJURY | 2 0.02 17.77 CD4 LYMPHOCYTES DECREASED | 1 0.01 17.78 CELL DEATH | 1 0.01 17.79 CELLULITIS | 10 0.10 17.89 CENTRAL NERVOUS SYSTEM LYMPHOMA | 1 0.01 17.90 CENTRAL VENOUS CATHETERISATION | 1 0.01 17.91 CENTRAL VENOUS PRESSURE INCREASED | 1 0.01 17.92 CEREBRAL ATROPHY | 1 0.01 17.93 CEREBRAL HAEMATOMA | 1 0.01 17.94 CEREBRAL HAEMORRHAGE | 5 0.05 17.99 CEREBRAL INFARCTION | 4 0.04 18.03 CEREBRAL ISCHAEMIA | 3 0.03 18.06 CEREBRAL VENTRICLE DILATATION | 1 0.01 18.07 CEREBROVASCULAR ACCIDENT | 26 0.26 18.33 CEREBROVASCULAR DISORDER | 1 0.01 18.34 CERVICAL DYSPLASIA | 2 0.02 18.36 CERVICAL SPINAL STENOSIS | 1 0.01 18.37 CHANGE OF BOWEL HABIT | 2 0.02 18.39 CHAPPED LIPS | 1 0.01 18.40 CHEILITIS | 2 0.02 18.42 CHEST DISCOMFORT | 28 0.28 18.70 CHEST PAIN | 48 0.48 19.18 CHEST X-RAY ABNORMAL | 1 0.01 19.19 CHILD ABUSE | 1 0.01 19.20 CHILLS | 25 0.25 19.45 CHOKING | 5 0.05 19.50 CHOKING SENSATION | 1 0.01 19.51 CHOLANGITIS | 1 0.01 19.52 CHOLECYSTECTOMY | 1 0.01 19.53 CHOLECYSTITIS | 2 0.02 19.55 CHOLECYSTITIS ACUTE | 1 0.01 19.56 CHOLELITHIASIS | 4 0.04 19.60 CHOLESTASIS | 5 0.05 19.65 CHONDROPATHY | 1 0.01 19.66 CHORIOCARCINOMA | 1 0.01 19.67 CHORIORETINOPATHY | 1 0.01 19.68 CHROMATURIA | 8 0.08 19.76 CHROMOSOME ANALYSIS ABNORMAL | 1 0.01 19.77 CHRONIC GRAFT VERSUS HOST DISEASE | 2 0.02 19.79 CHRONIC HEPATIC FAILURE | 1 0.01 19.80 CHRONIC HEPATITIS | 1 0.01 19.81 CHRONIC MYELOID LEUKAEMIA | 2 0.02 19.83 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 9 0.09 19.92 CHRONIC SINUSITIS | 1 0.01 19.93 CIRCULATORY COLLAPSE | 7 0.07 20.00 CIRCUMORAL OEDEMA | 1 0.01 20.01 CIRCUMSTANCE OR INFORMATION CAPABLE O.. | 1 0.01 20.02 CLAVICLE FRACTURE | 3 0.03 20.05 CLONIC CONVULSION | 1 0.01 20.06 CLOSTRIDIAL INFECTION | 2 0.02 20.08 CLOSTRIDIUM DIFFICILE COLITIS | 4 0.04 20.12 CLOSTRIDIUM DIFFICILE TOXIN TEST | 1 0.01 20.13 CLUSTER HEADACHE | 1 0.01 20.14 CNS VENTRICULITIS | 1 0.01 20.15 COAGULATION TEST ABNORMAL | 1 0.01 20.16 COAGULOPATHY | 5 0.05 20.21 COELIAC DISEASE | 2 0.02 20.23 COGNITIVE DISORDER | 2 0.02 20.25 COLD SWEAT | 1 0.01 20.26 COLECTOMY TOTAL | 1 0.01 20.27 COLITIS | 17 0.17 20.44 COLITIS ISCHAEMIC | 2 0.02 20.46 COLITIS ULCERATIVE | 21 0.21 20.67 COLONIC OBSTRUCTION | 2 0.02 20.69 COLONIC POLYP | 2 0.02 20.71 COLONIC STENOSIS | 1 0.01 20.72 COMA | 14 0.14 20.86 COMMINUTED FRACTURE | 1 0.01 20.87 COMPLEMENT FACTOR C3 DECREASED | 1 0.01 20.88 COMPLETED SUICIDE | 15 0.15 21.03 COMPLEX REGIONAL PAIN SYNDROME | 1 0.01 21.04 COMPLICATION OF DEVICE INSERTION | 2 0.02 21.06 COMPLICATION OF DEVICE REMOVAL | 4 0.04 21.10 COMPLICATIONS OF TRANSPLANTED KIDNEY | 1 0.01 21.11 COMPLICATIONS OF TRANSPLANTED LIVER | 1 0.01 21.12 COMPUTERISED TOMOGRAM ABNORMAL | 3 0.03 21.15 CONDITION AGGRAVATED | 16 0.16 21.31 CONDUCTION DISORDER | 1 0.01 21.32 CONFUSIONAL STATE | 39 0.39 21.71 CONGENITAL ANOMALY | 27 0.27 21.98 CONGENITAL AORTIC ANOMALY | 1 0.01 21.99 CONGENITAL BLADDER ANOMALY | 1 0.01 22.00 CONGENITAL CARDIOVASCULAR ANOMALY | 1 0.01 22.01 CONGENITAL CENTRAL NERVOUS SYSTEM ANO.. | 4 0.04 22.05 CONGENITAL CEREBELLAR AGENESIS | 1 0.01 22.06 CONGENITAL ENDOCRINE ANOMALY | 1 0.01 22.07 CONGENITAL HAND MALFORMATION | 2 0.02 22.09 CONGENITAL HYDROCEPHALUS | 2 0.02 22.11 CONGENITAL MITRAL VALVE INCOMPETENCE | 1 0.01 22.12 CONGENITAL NOSE MALFORMATION | 2 0.02 22.14 CONGENITAL PULMONARY HYPERTENSION | 1 0.01 22.15 CONGENITAL PULMONARY VALVE ATRESIA | 1 0.01 22.16 CONGENITAL TRICUSPID VALVE ATRESIA | 1 0.01 22.17 CONGENITAL TRICUSPID VALVE STENOSIS | 1 0.01 22.18 CONGESTIVE CARDIOMYOPATHY | 1 0.01 22.19 CONJUNCTIVAL DISORDER | 1 0.01 22.20 CONJUNCTIVAL HAEMORRHAGE | 1 0.01 22.21 CONJUNCTIVAL HYPERAEMIA | 1 0.01 22.22 CONJUNCTIVITIS | 1 0.01 22.23 CONJUNCTIVITIS INFECTIVE | 2 0.02 22.25 CONSTIPATION | 26 0.26 22.51 CONTACT LENS COMPLICATION | 1 0.01 22.52 CONTRACTED BLADDER | 1 0.01 22.53 CONTUSION | 7 0.07 22.60 CONVERSION DISORDER | 2 0.02 22.62 CONVULSION | 47 0.47 23.09 COORDINATION ABNORMAL | 4 0.04 23.13 CORNEAL PERFORATION | 1 0.01 23.14 CORONARY ARTERY BYPASS | 2 0.02 23.16 CORONARY ARTERY DISEASE | 4 0.04 23.20 CORONARY ARTERY OCCLUSION | 1 0.01 23.21 CORONARY ARTERY STENOSIS | 7 0.07 23.28 CORONARY ARTERY THROMBOSIS | 1 0.01 23.29 COUGH | 21 0.21 23.50 CROHN'S DISEASE | 14 0.14 23.64 CRYING | 16 0.16 23.80 CRYPTOSPORIDIOSIS INFECTION | 1 0.01 23.81 CUTANEOUS LUPUS ERYTHEMATOSUS | 1 0.01 23.82 CUTIS LAXA | 1 0.01 23.83 CYANOSIS | 8 0.08 23.91 CYSTATIN C INCREASED | 1 0.01 23.92 CYSTIC LYMPHANGIOMA | 1 0.01 23.93 CYSTITIS | 4 0.04 23.97 CYSTOCELE | 1 0.01 23.98 CYTOGENETIC ABNORMALITY | 1 0.01 23.99 CYTOLYTIC HEPATITIS | 5 0.05 24.04 CYTOMEGALOVIRUS COLITIS | 1 0.01 24.05 CYTOMEGALOVIRUS INFECTION | 1 0.01 24.06 CYTOMEGALOVIRUS MYOCARDITIS | 1 0.01 24.07 DANDRUFF | 1 0.01 24.08 DANDY-WALKER SYNDROME | 1 0.01 24.09 DEAFNESS | 8 0.08 24.17 DEAFNESS BILATERAL | 2 0.02 24.19 DEAFNESS UNILATERAL | 2 0.02 24.21 DEATH | 292 2.92 27.13 DECREASED ACTIVITY | 3 0.03 27.16 DECREASED APPETITE | 15 0.15 27.31 DECREASED INTEREST | 3 0.03 27.34 DECUBITUS ULCER | 1 0.01 27.35 DEEP VEIN THROMBOSIS | 12 0.12 27.47 DEFAECATION URGENCY | 1 0.01 27.48 DEFORMITY | 1 0.01 27.49 DEHYDRATION | 28 0.28 27.77 DELIRIUM | 5 0.05 27.82 DELUSION | 3 0.03 27.85 DELUSION OF REPLACEMENT | 1 0.01 27.86 DEMENTIA | 4 0.04 27.90 DEMENTIA ALZHEIMER'S TYPE | 2 0.02 27.92 DEMYELINATION | 4 0.04 27.96 DENTAL ALVEOLAR ANOMALY | 1 0.01 27.97 DENTAL CARIES | 4 0.04 28.01 DENTAL PULP DISORDER | 1 0.01 28.02 DEPENDENCE | 1 0.01 28.03 DEPENDENCE ON RESPIRATOR | 1 0.01 28.04 DEPERSONALISATION | 1 0.01 28.05 DEPRESSED LEVEL OF CONSCIOUSNESS | 10 0.10 28.15 DEPRESSED MOOD | 10 0.10 28.25 DEPRESSION | 81 0.81 29.06 DEPRESSION SUICIDAL | 1 0.01 29.07 DERMAL CYST | 2 0.02 29.09 DERMATITIS | 2 0.02 29.11 DERMATITIS ALLERGIC | 1 0.01 29.12 DERMATITIS BULLOUS | 3 0.03 29.15 DERMATITIS EXFOLIATIVE | 5 0.05 29.20 DERMATITIS EXFOLIATIVE GENERALISED | 1 0.01 29.21 DERMATITIS PSORIASIFORM | 1 0.01 29.22 DERMATOMYOSITIS | 1 0.01 29.23 DETACHMENT OF RETINAL PIGMENT EPITHEL.. | 1 0.01 29.24 DEVICE BREAKAGE | 1 0.01 29.25 DEVICE FAILURE | 1 0.01 29.26 DEVICE INEFFECTIVE | 1 0.01 29.27 DIABETES INSIPIDUS | 1 0.01 29.28 DIABETES MELLITUS | 20 0.20 29.48 DIABETIC KETOACIDOSIS | 1 0.01 29.49 DIABETIC RETINOPATHY | 1 0.01 29.50 DIALYSIS | 5 0.05 29.55 DIAPHRAGMATIC HERNIA | 3 0.03 29.58 DIARRHOEA | 68 0.68 30.26 DIARRHOEA HAEMORRHAGIC | 1 0.01 30.27 DIARRHOEA NEONATAL | 1 0.01 30.28 DIASTOLIC DYSFUNCTION | 1 0.01 30.29 DIFFUSE ALVEOLAR DAMAGE | 1 0.01 30.30 DIPLEGIA | 1 0.01 30.31 DIPLOPIA | 10 0.10 30.41 DISABILITY | 1 0.01 30.42 DISCOMFORT | 2 0.02 30.44 DISEASE COMPLICATION | 2 0.02 30.46 DISEASE PROGRESSION | 33 0.33 30.79 DISEASE RECURRENCE | 3 0.03 30.82 DISORIENTATION | 12 0.12 30.94 DISSEMINATED INTRAVASCULAR COAGULATION | 6 0.06 31.00 DISSEMINATED TUBERCULOSIS | 1 0.01 31.01 DISSOCIATION | 2 0.02 31.03 DISTURBANCE IN ATTENTION | 13 0.13 31.16 DISTURBANCE IN SOCIAL BEHAVIOUR | 1 0.01 31.17 DIVERTICULITIS | 2 0.02 31.19 DIZZINESS | 111 1.11 32.30 DIZZINESS POSTURAL | 1 0.01 32.31 DROWNING | 1 0.01 32.32 DRUG ABUSE | 5 0.05 32.37 DRUG ADMINISTERED AT INAPPROPRIATE SITE | 2 0.02 32.39 DRUG ADMINISTRATION ERROR | 9 0.09 32.48 DRUG DEPENDENCE | 6 0.06 32.54 DRUG DISPENSING ERROR | 3 0.03 32.57 DRUG DIVERSION | 1 0.01 32.58 DRUG DOSE OMISSION | 3 0.03 32.61 DRUG EFFECT DECREASED | 5 0.05 32.66 DRUG EFFECT INCREASED | 1 0.01 32.67 DRUG ERUPTION | 6 0.06 32.73 DRUG EXPOSURE BEFORE PREGNANCY | 2 0.02 32.75 DRUG EXPOSURE DURING PREGNANCY | 51 0.51 33.26 DRUG EXPOSURE VIA BREAST MILK | 1 0.01 33.27 DRUG HYPERSENSITIVITY | 8 0.08 33.35 DRUG INEFFECTIVE | 127 1.27 34.62 DRUG INEFFECTIVE FOR UNAPPROVED INDIC.. | 4 0.04 34.66 DRUG INTERACTION | 30 0.30 34.96 DRUG INTOLERANCE | 5 0.05 35.01 DRUG LEVEL INCREASED | 2 0.02 35.03 DRUG RASH WITH EOSINOPHILIA AND SYSTE.. | 3 0.03 35.06 DRUG RESISTANCE | 1 0.01 35.07 DRUG SCREEN POSITIVE | 1 0.01 35.08 DRUG TOLERANCE INCREASED | 1 0.01 35.09 DRUG TOXICITY | 18 0.18 35.27 DRUG WITHDRAWAL SYNDROME | 8 0.08 35.35 DRUG WITHDRAWAL SYNDROME NEONATAL | 10 0.10 35.45 DRY EYE | 1 0.01 35.46 DRY MOUTH | 13 0.13 35.59 DRY SKIN | 14 0.14 35.73 DRY THROAT | 2 0.02 35.75 DYSARTHRIA | 11 0.11 35.86 DYSENTERY | 3 0.03 35.89 DYSGEUSIA | 8 0.08 35.97 DYSKINESIA | 8 0.08 36.05 DYSLALIA | 1 0.01 36.06 DYSMENORRHOEA | 2 0.02 36.08 DYSMORPHISM | 8 0.08 36.16 DYSPAREUNIA | 1 0.01 36.17 DYSPEPSIA | 13 0.13 36.30 DYSPHAGIA | 16 0.16 36.46 DYSPHONIA | 8 0.08 36.54 DYSPHORIA | 1 0.01 36.55 DYSPNOEA | 106 1.06 37.61 DYSPNOEA EXERTIONAL | 4 0.04 37.65 DYSSTASIA | 2 0.02 37.67 DYSTONIA | 4 0.04 37.71 DYSURIA | 8 0.08 37.79 EAR DISCOMFORT | 1 0.01 37.80 EAR INFECTION | 1 0.01 37.81 EAR MALFORMATION | 7 0.07 37.88 EAR PAIN | 3 0.03 37.91 EARLY MORNING AWAKENING | 1 0.01 37.92 EATING DISORDER | 11 0.11 38.03 ECTOPIC PREGNANCY | 2 0.02 38.05 ECTOPIC PREGNANCY WITH INTRAUTERINE D.. | 2 0.02 38.07 ECZEMA | 4 0.04 38.11 EDUCATIONAL PROBLEM | 2 0.02 38.13 EJECTION FRACTION DECREASED | 1 0.01 38.14 ELECTROCARDIOGRAM ABNORMAL | 1 0.01 38.15 ELECTROCARDIOGRAM AMBULATORY ABNORMAL | 1 0.01 38.16 ELECTROCARDIOGRAM CHANGE | 1 0.01 38.17 ELECTROCARDIOGRAM QT PROLONGED | 7 0.07 38.24 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL | 1 0.01 38.25 ELECTROCARDIOGRAM ST SEGMENT ELEVATION | 7 0.07 38.32 ELECTROENCEPHALOGRAM | 1 0.01 38.33 ELECTROENCEPHALOGRAM ABNORMAL | 5 0.05 38.38 ELECTROLYTE DEPLETION | 1 0.01 38.39 ELECTROLYTE IMBALANCE | 2 0.02 38.41 ELECTROMECHANICAL DISSOCIATION | 1 0.01 38.42 ELEVATED MOOD | 1 0.01 38.43 EMOTIONAL DISORDER | 5 0.05 38.48 EMOTIONAL DISTRESS | 11 0.11 38.59 EMPHYSEMA | 2 0.02 38.61 ENCEPHALITIS | 4 0.04 38.65 ENCEPHALITIS HERPES | 2 0.02 38.67 ENCEPHALOPATHY | 6 0.06 38.73 ENDODONTIC PROCEDURE | 1 0.01 38.74 ENDOMETRIAL DISORDER | 2 0.02 38.76 ENDOMETRIAL HYPERTROPHY | 1 0.01 38.77 ENDOMETRIAL NEOPLASM | 1 0.01 38.78 ENERGY INCREASED | 1 0.01 38.79 ENTERITIS | 4 0.04 38.83 ENTERITIS INFECTIOUS | 1 0.01 38.84 ENTEROCOCCAL INFECTION | 1 0.01 38.85 ENTEROCOLITIS BACTERIAL | 1 0.01 38.86 ENTEROCOLITIS HAEMORRHAGIC | 2 0.02 38.88 ENTEROCOLITIS INFECTIOUS | 1 0.01 38.89 EOSINOPHILIA | 6 0.06 38.95 EPICONDYLITIS | 1 0.01 38.96 EPIGLOTTITIS | 1 0.01 38.97 EPILEPSY | 5 0.05 39.02 EPIPHYSIOLYSIS | 4 0.04 39.06 EPISTAXIS | 13 0.13 39.19 EPSTEIN-BARR VIRUS INFECTION | 1 0.01 39.20 ERECTILE DYSFUNCTION | 4 0.04 39.24 EROSIVE OESOPHAGITIS | 1 0.01 39.25 ERUCTATION | 3 0.03 39.28 ERYTHEMA | 30 0.30 39.58 ERYTHEMA MULTIFORME | 1 0.01 39.59 ESCHERICHIA BACTERAEMIA | 1 0.01 39.60 ESCHERICHIA URINARY TRACT INFECTION | 1 0.01 39.61 ESSENTIAL HYPERTENSION | 1 0.01 39.62 EUPHORIC MOOD | 4 0.04 39.66 EXCESSIVE GRANULATION TISSUE | 1 0.01 39.67 EXCORIATION | 1 0.01 39.68 EXERCISE TOLERANCE DECREASED | 1 0.01 39.69 EXFOLIATIVE RASH | 2 0.02 39.71 EXOMPHALOS | 2 0.02 39.73 EXOSTOSIS | 2 0.02 39.75 EXPIRED DRUG ADMINISTERED | 2 0.02 39.77 EXTRAMEDULLARY HAEMOPOIESIS | 1 0.01 39.78 EXTRAPYRAMIDAL DISORDER | 1 0.01 39.79 EXTRASYSTOLES | 3 0.03 39.82 EXTRAVASATION | 4 0.04 39.86 EYE DISCHARGE | 1 0.01 39.87 EYE DISORDER | 10 0.10 39.97 EYE HAEMORRHAGE | 3 0.03 40.00 EYE INFECTION | 1 0.01 40.01 EYE IRRITATION | 2 0.02 40.03 EYE MOVEMENT DISORDER | 1 0.01 40.04 EYE PAIN | 4 0.04 40.08 EYE PRURITUS | 7 0.07 40.15 EYE ROLLING | 1 0.01 40.16 EYE SWELLING | 4 0.04 40.20 EYELID OEDEMA | 2 0.02 40.22 EYELID PTOSIS | 5 0.05 40.27 FACE OEDEMA | 3 0.03 40.30 FACIAL BONES FRACTURE | 1 0.01 40.31 FACIAL PAIN | 3 0.03 40.34 FACIAL PALSY | 2 0.02 40.36 FACIAL PARESIS | 1 0.01 40.37 FAECAL INCONTINENCE | 2 0.02 40.39 FAECAL VOMITING | 1 0.01 40.40 FAECALOMA | 1 0.01 40.41 FAECES DISCOLOURED | 7 0.07 40.48 FAILURE OF IMPLANT | 1 0.01 40.49 FAILURE TO THRIVE | 2 0.02 40.51 FALL | 36 0.36 40.87 FALLOT'S TETRALOGY | 2 0.02 40.89 FANCONI SYNDROME ACQUIRED | 1 0.01 40.90 FAT EMBOLISM | 2 0.02 40.92 FATIGUE | 70 0.70 41.62 FEAR | 7 0.07 41.69 FEAR OF DEATH | 1 0.01 41.70 FEBRILE NEUTROPENIA | 28 0.28 41.98 FEEDING DISORDER NEONATAL | 1 0.01 41.99 FEEDING DISORDER OF INFANCY OR EARLY .. | 1 0.01 42.00 FEELING ABNORMAL | 42 0.42 42.42 FEELING COLD | 2 0.02 42.44 FEELING DRUNK | 4 0.04 42.48 FEELING HOT | 12 0.12 42.60 FEELING JITTERY | 9 0.09 42.69 FEELING OF BODY TEMPERATURE CHANGE | 1 0.01 42.70 FEELING OF DESPAIR | 2 0.02 42.72 FEELINGS OF WORTHLESSNESS | 1 0.01 42.73 FEMORAL NECK FRACTURE | 1 0.01 42.74 FEMUR FRACTURE | 1 0.01 42.75 FIBRINOUS BRONCHITIS | 1 0.01 42.76 FIBROMYALGIA | 1 0.01 42.77 FIBROSIS | 1 0.01 42.78 FIBROUS DYSPLASIA OF BONE | 1 0.01 42.79 FISTULA | 2 0.02 42.81 FISTULA DISCHARGE | 1 0.01 42.82 FLANK PAIN | 2 0.02 42.84 FLAT AFFECT | 2 0.02 42.86 FLATULENCE | 9 0.09 42.95 FLUID OVERLOAD | 1 0.01 42.96 FLUID RETENTION | 6 0.06 43.02 FLUSHING | 24 0.24 43.26 FOAMING AT MOUTH | 1 0.01 43.27 FOETAL DISTRESS SYNDROME | 1 0.01 43.28 FOETAL MALFORMATION | 1 0.01 43.29 FOETAL MOVEMENTS DECREASED | 1 0.01 43.30 FOLLICULITIS | 4 0.04 43.34 FOOD INTERACTION | 1 0.01 43.35 FOOT DEFORMITY | 1 0.01 43.36 FOOT FRACTURE | 1 0.01 43.37 FOOT OPERATION | 1 0.01 43.38 FOREIGN BODY SENSATION IN EYES | 2 0.02 43.40 FOREIGN BODY TRAUMA | 3 0.03 43.43 FORMICATION | 1 0.01 43.44 FRACTURE | 1 0.01 43.45 FRACTURE MALUNION | 1 0.01 43.46 FRACTURE TREATMENT | 1 0.01 43.47 FREEZING PHENOMENON | 1 0.01 43.48 FREQUENT BOWEL MOVEMENTS | 1 0.01 43.49 FRUSTRATION | 3 0.03 43.52 FULL BLOOD COUNT DECREASED | 2 0.02 43.54 FUNGAL INFECTION | 4 0.04 43.58 GAIT DISTURBANCE | 20 0.20 43.78 GALACTOCELE | 1 0.01 43.79 GALACTORRHOEA | 2 0.02 43.81 GALLBLADDER CANCER RECURRENT | 1 0.01 43.82 GALLBLADDER DISORDER | 1 0.01 43.83 GAMBLING | 2 0.02 43.85 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 6 0.06 43.91 GANGRENE | 1 0.01 43.92 GASTRIC CANCER | 2 0.02 43.94 GASTRIC DISORDER | 1 0.01 43.95 GASTRIC HAEMORRHAGE | 4 0.04 43.99 GASTRIC POLYPS | 1 0.01 44.00 GASTRIC ULCER | 4 0.04 44.04 GASTRIC ULCER HAEMORRHAGE | 3 0.03 44.07 GASTRITIS | 5 0.05 44.12 GASTROENTERITIS | 3 0.03 44.15 GASTROENTERITIS STAPHYLOCOCCAL | 1 0.01 44.16 GASTROENTERITIS VIRAL | 3 0.03 44.19 GASTROINTESTINAL CANDIDIASIS | 1 0.01 44.20 GASTROINTESTINAL CARCINOMA | 1 0.01 44.21 GASTROINTESTINAL DISORDER | 12 0.12 44.33 GASTROINTESTINAL HAEMORRHAGE | 12 0.12 44.45 GASTROINTESTINAL INFECTION | 1 0.01 44.46 GASTROINTESTINAL MOTILITY DISORDER | 2 0.02 44.48 GASTROINTESTINAL PAIN | 2 0.02 44.50 GASTROINTESTINAL PERFORATION | 2 0.02 44.52 GASTROOESOPHAGEAL REFLUX DISEASE | 11 0.11 44.63 GASTROSTOMY TUBE INSERTION | 1 0.01 44.64 GENERAL PHYSICAL HEALTH DETERIORATION | 13 0.13 44.77 GENERALISED ANXIETY DISORDER | 1 0.01 44.78 GENERALISED ERYTHEMA | 6 0.06 44.84 GENERALISED OEDEMA | 2 0.02 44.86 GENITAL HAEMORRHAGE | 1 0.01 44.87 GENITAL PAIN | 2 0.02 44.89 GENOTYPE DRUG RESISTANCE TEST NEGATIVE | 1 0.01 44.90 GINGIVAL ABSCESS | 2 0.02 44.92 GINGIVAL BLEEDING | 2 0.02 44.94 GINGIVAL ERYTHEMA | 1 0.01 44.95 GINGIVAL HYPERTROPHY | 1 0.01 44.96 GINGIVAL SWELLING | 1 0.01 44.97 GINGIVITIS | 1 0.01 44.98 GLAUCOMA | 1 0.01 44.99 GLOMERULAR FILTRATION RATE DECREASED | 3 0.03 45.02 GLOMERULONEPHRITIS | 1 0.01 45.03 GLOMERULONEPHRITIS MEMBRANOUS | 1 0.01 45.04 GLOMERULOSCLEROSIS | 1 0.01 45.05 GLOSSODYNIA | 1 0.01 45.06 GLUCOSE TOLERANCE INCREASED | 1 0.01 45.07 GLYCOSURIA | 1 0.01 45.08 GLYCOSYLATED HAEMOGLOBIN INCREASED | 1 0.01 45.09 GOUT | 5 0.05 45.14 GRAFT THROMBOSIS | 1 0.01 45.15 GRAFT VERSUS HOST DISEASE | 3 0.03 45.18 GRAND MAL CONVULSION | 4 0.04 45.22 GRANULOCYTE COUNT DECREASED | 1 0.01 45.23 GRANULOCYTOPENIA | 1 0.01 45.24 GRIP STRENGTH DECREASED | 2 0.02 45.26 GROWTH RETARDATION | 2 0.02 45.28 GYNAECOMASTIA | 4 0.04 45.32 HAEMANGIOMA | 1 0.01 45.33 HAEMATEMESIS | 4 0.04 45.37 HAEMATOCHEZIA | 10 0.10 45.47 HAEMATOCRIT DECREASED | 8 0.08 45.55 HAEMATOLOGY TEST ABNORMAL | 1 0.01 45.56 HAEMATOMA | 3 0.03 45.59 HAEMATURIA | 6 0.06 45.65 HAEMODIALYSIS | 1 0.01 45.66 HAEMOGLOBIN DECREASED | 21 0.21 45.87 HAEMOLYSIS | 1 0.01 45.88 HAEMOLYTIC ANAEMIA | 3 0.03 45.91 HAEMOLYTIC URAEMIC SYNDROME | 7 0.07 45.98 HAEMOPTYSIS | 3 0.03 46.01 HAEMORRHAGE | 24 0.24 46.25 HAEMORRHAGE INTRACRANIAL | 5 0.05 46.30 HAEMORRHAGE URINARY TRACT | 3 0.03 46.33 HAEMORRHAGIC ANAEMIA | 1 0.01 46.34 HAEMORRHAGIC DISORDER | 1 0.01 46.35 HAEMORRHOIDS | 3 0.03 46.38 HAEMOTHORAX | 1 0.01 46.39 HAIR GROWTH ABNORMAL | 1 0.01 46.40 HALLUCINATION | 25 0.25 46.65 HALLUCINATION, AUDITORY | 3 0.03 46.68 HALLUCINATION, VISUAL | 4 0.04 46.72 HALLUCINATIONS, MIXED | 2 0.02 46.74 HAND FRACTURE | 2 0.02 46.76 HANGOVER | 7 0.07 46.83 HBV-DNA POLYMERASE INCREASED | 2 0.02 46.85 HEAD DISCOMFORT | 1 0.01 46.86 HEAD INJURY | 3 0.03 46.89 HEAD TITUBATION | 1 0.01 46.90 HEADACHE | 78 0.78 47.68 HEARING IMPAIRED | 2 0.02 47.70 HEART DISEASE CONGENITAL | 3 0.03 47.73 HEART INJURY | 9 0.09 47.82 HEART RATE ABNORMAL | 1 0.01 47.83 HEART RATE DECREASED | 3 0.03 47.86 HEART RATE INCREASED | 21 0.21 48.07 HEART RATE IRREGULAR | 5 0.05 48.12 HEMIPARESIS | 4 0.04 48.16 HEMIPLEGIA | 6 0.06 48.22 HENOCH-SCHONLEIN PURPURA | 2 0.02 48.24 HEPATECTOMY | 1 0.01 48.25 HEPATIC ARTERY THROMBOSIS | 1 0.01 48.26 HEPATIC ATROPHY | 1 0.01 48.27 HEPATIC CANCER METASTATIC | 1 0.01 48.28 HEPATIC CIRRHOSIS | 5 0.05 48.33 HEPATIC CONGESTION | 1 0.01 48.34 HEPATIC ENCEPHALOPATHY | 1 0.01 48.35 HEPATIC ENZYME ABNORMAL | 2 0.02 48.37 HEPATIC ENZYME INCREASED | 28 0.28 48.65 HEPATIC FAILURE | 12 0.12 48.77 HEPATIC FIBROSIS | 2 0.02 48.79 HEPATIC FUNCTION ABNORMAL | 12 0.12 48.91 HEPATIC HAEMORRHAGE | 1 0.01 48.92 HEPATIC INFARCTION | 1 0.01 48.93 HEPATIC NECROSIS | 1 0.01 48.94 HEPATIC NEOPLASM | 1 0.01 48.95 HEPATIC NEOPLASM MALIGNANT | 3 0.03 48.98 HEPATIC PAIN | 1 0.01 48.99 HEPATIC STEATOSIS | 3 0.03 49.02 HEPATITIS | 5 0.05 49.07 HEPATITIS A ANTIBODY POSITIVE | 1 0.01 49.08 HEPATITIS ACUTE | 1 0.01 49.09 HEPATITIS B | 3 0.03 49.12 HEPATITIS C | 8 0.08 49.20 HEPATITIS C POSITIVE | 1 0.01 49.21 HEPATITIS C VIRUS | 1 0.01 49.22 HEPATITIS CHOLESTATIC | 2 0.02 49.24 HEPATITIS FULMINANT | 4 0.04 49.28 HEPATITIS VIRAL | 1 0.01 49.29 HEPATOCELLULAR INJURY | 4 0.04 49.33 HEPATOMEGALY | 2 0.02 49.35 HEPATOTOXICITY | 3 0.03 49.38 HERNIA | 5 0.05 49.43 HERNIA CONGENITAL | 1 0.01 49.44 HERPES OPHTHALMIC | 1 0.01 49.45 HERPES ZOSTER | 3 0.03 49.48 HIATUS HERNIA | 5 0.05 49.53 HICCUPS | 1 0.01 49.54 HIGH ARCHED PALATE | 1 0.01 49.55 HIGH DENSITY LIPOPROTEIN DECREASED | 1 0.01 49.56 HIP ARTHROPLASTY | 2 0.02 49.58 HIP FRACTURE | 3 0.03 49.61 HODGKIN'S DISEASE | 1 0.01 49.62 HODGKIN'S DISEASE RECURRENT | 1 0.01 49.63 HOMICIDE | 2 0.02 49.65 HORMONE LEVEL ABNORMAL | 2 0.02 49.67 HOSPITALISATION | 12 0.12 49.79 HOT FLUSH | 8 0.08 49.87 HUMAN BITE | 1 0.01 49.88 HUMERUS FRACTURE | 2 0.02 49.90 HYDROCEPHALUS | 5 0.05 49.95 HYDRONEPHROSIS | 4 0.04 49.99 HYPERACUSIS | 2 0.02 50.01 HYPERBILIRUBINAEMIA | 3 0.03 50.04 HYPERCALCAEMIA | 1 0.01 50.05 HYPERCAPNIC ENCEPHALOPATHY | 1 0.01 50.06 HYPERCHOLESTEROLAEMIA | 3 0.03 50.09 HYPERGLYCAEMIA | 9 0.09 50.18 HYPERHIDROSIS | 37 0.37 50.55 HYPERKALAEMIA | 8 0.08 50.63 HYPERLIPIDAEMIA | 12 0.12 50.75 HYPERNATRAEMIA | 1 0.01 50.76 HYPERPARATHYROIDISM | 1 0.01 50.77 HYPERPROLACTINAEMIA | 2 0.02 50.79 HYPERREFLEXIA | 1 0.01 50.80 HYPERSENSITIVITY | 60 0.60 51.40 HYPERSOMNIA | 7 0.07 51.47 HYPERSPLENISM | 1 0.01 51.48 HYPERTELORISM OF ORBIT | 1 0.01 51.49 HYPERTENSION | 45 0.45 51.94 HYPERTENSIVE CRISIS | 5 0.05 51.99 HYPERTHERMIA | 3 0.03 52.02 HYPERTHYROIDISM | 2 0.02 52.04 HYPERTONIA | 2 0.02 52.06 HYPERTRIGLYCERIDAEMIA | 1 0.01 52.07 HYPERVIGILANCE | 1 0.01 52.08 HYPHAEMA | 1 0.01 52.09 HYPOACUSIS | 4 0.04 52.13 HYPOAESTHESIA | 20 0.20 52.33 HYPOAESTHESIA FACIAL | 2 0.02 52.35 HYPOAESTHESIA ORAL | 3 0.03 52.38 HYPOALBUMINAEMIA | 3 0.03 52.41 HYPOCALCAEMIA | 7 0.07 52.48 HYPOGAMMAGLOBULINAEMIA | 1 0.01 52.49 HYPOGLOBULINAEMIA | 1 0.01 52.50 HYPOGLOSSAL NERVE PARESIS | 1 0.01 52.51 HYPOGLYCAEMIA | 7 0.07 52.58 HYPOKALAEMIA | 7 0.07 52.65 HYPOKINESIA | 1 0.01 52.66 HYPOMAGNESAEMIA | 2 0.02 52.68 HYPOMANIA | 2 0.02 52.70 HYPONATRAEMIA | 11 0.11 52.81 HYPOPITUITARISM | 1 0.01 52.82 HYPOPLASTIC LEFT HEART SYNDROME | 2 0.02 52.84 HYPOPNOEA | 1 0.01 52.85 HYPOPROTEINAEMIA | 2 0.02 52.87 HYPOREFLEXIA | 2 0.02 52.89 HYPOTENSION | 59 0.59 53.48 HYPOTHERMIA | 1 0.01 53.49 HYPOTHYROIDISM | 5 0.05 53.54 HYPOTONIA | 3 0.03 53.57 HYPOVENTILATION | 2 0.02 53.59 HYPOVITAMINOSIS | 1 0.01 53.60 HYPOVOLAEMIA | 3 0.03 53.63 HYPOVOLAEMIC SHOCK | 3 0.03 53.66 HYPOXIA | 7 0.07 53.73 HYPOXIC ENCEPHALOPATHY | 2 0.02 53.75 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 5 0.05 53.80 IDIOSYNCRATIC DRUG REACTION | 1 0.01 53.81 IIIRD NERVE DISORDER | 1 0.01 53.82 ILEAL PERFORATION | 1 0.01 53.83 ILEAL STENOSIS | 1 0.01 53.84 ILEITIS | 3 0.03 53.87 ILEOSTOMY | 1 0.01 53.88 ILEUS | 4 0.04 53.92 ILL-DEFINED DISORDER | 9 0.09 54.01 IMMOBILE | 5 0.05 54.06 IMMUNE RECONSTITUTION SYNDROME | 1 0.01 54.07 IMMUNE SYSTEM DISORDER | 1 0.01 54.08 IMMUNODEFICIENCY | 3 0.03 54.11 IMMUNOSUPPRESSION | 2 0.02 54.13 IMPAIRED DRIVING ABILITY | 2 0.02 54.15 IMPAIRED HEALING | 3 0.03 54.18 IMPAIRED WORK ABILITY | 3 0.03 54.21 INABILITY TO CRAWL | 1 0.01 54.22 INAPPROPRIATE AFFECT | 1 0.01 54.23 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 3 0.03 54.26 INAPPROPRIATE SCHEDULE OF DRUG ADMINI.. | 10 0.10 54.36 INBORN ERROR OF METABOLISM | 1 0.01 54.37 INCISION SITE INFECTION | 1 0.01 54.38 INCOHERENT | 3 0.03 54.41 INCONTINENCE | 1 0.01 54.42 INCORRECT DOSE ADMINISTERED | 6 0.06 54.48 INCORRECT DRUG ADMINISTRATION DURATION | 1 0.01 54.49 INCORRECT DRUG ADMINISTRATION RATE | 2 0.02 54.51 INCORRECT ROUTE OF DRUG ADMINISTRATION | 6 0.06 54.57 INCREASED APPETITE | 4 0.04 54.61 INCREASED UPPER AIRWAY SECRETION | 1 0.01 54.62 INDIFFERENCE | 1 0.01 54.63 INFARCTION | 2 0.02 54.65 INFECTED NEOPLASM | 1 0.01 54.66 INFECTED SKIN ULCER | 1 0.01 54.67 INFECTION | 13 0.13 54.80 INFECTION IN AN IMMUNOCOMPROMISED HOST | 1 0.01 54.81 INFECTIOUS MONONUCLEOSIS | 1 0.01 54.82 INFERTILITY FEMALE | 2 0.02 54.84 INFLAMMATION | 3 0.03 54.87 INFLAMMATORY BOWEL DISEASE | 66 0.66 55.53 INFLAMMATORY MYOFIBROBLASTIC TUMOUR | 1 0.01 55.54 INFLUENZA | 6 0.06 55.60 INFLUENZA LIKE ILLNESS | 11 0.11 55.71 INFUSION RELATED REACTION | 6 0.06 55.77 INFUSION SITE CELLULITIS | 1 0.01 55.78 INFUSION SITE EXTRAVASATION | 1 0.01 55.79 INFUSION SITE INFECTION | 1 0.01 55.80 INFUSION SITE REACTION | 1 0.01 55.81 INFUSION SITE SWELLING | 1 0.01 55.82 INGUINAL HERNIA | 1 0.01 55.83 INITIAL INSOMNIA | 54 0.54 56.37 INJECTION SITE BRUISING | 3 0.03 56.40 INJECTION SITE CELLULITIS | 1 0.01 56.41 INJECTION SITE ERYTHEMA | 9 0.09 56.50 INJECTION SITE INDURATION | 3 0.03 56.53 INJECTION SITE INFLAMMATION | 4 0.04 56.57 INJECTION SITE IRRITATION | 3 0.03 56.60 INJECTION SITE MASS | 1 0.01 56.61 INJECTION SITE NECROSIS | 1 0.01 56.62 INJECTION SITE PAIN | 8 0.08 56.70 INJECTION SITE PARAESTHESIA | 1 0.01 56.71 INJECTION SITE PRURITUS | 2 0.02 56.73 INJECTION SITE RASH | 2 0.02 56.75 INJECTION SITE REACTION | 11 0.11 56.86 INJECTION SITE SWELLING | 3 0.03 56.89 INJECTION SITE VESICLES | 1 0.01 56.90 INJURY | 11 0.11 57.01 INSOMNIA | 49 0.49 57.50 INTENTION TREMOR | 1 0.01 57.51 INTENTIONAL DRUG MISUSE | 8 0.08 57.59 INTENTIONAL OVERDOSE | 7 0.07 57.66 INTENTIONAL SELF-INJURY | 4 0.04 57.70 INTERCEPTED DRUG ADMINISTRATION ERROR | 1 0.01 57.71 INTERCEPTED DRUG DISPENSING ERROR | 1 0.01 57.72 INTERCEPTED MEDICATION ERROR | 1 0.01 57.73 INTERMITTENT CLAUDICATION | 1 0.01 57.74 INTERNAL INJURY | 1 0.01 57.75 INTERNATIONAL NORMALISED RATIO INCREA.. | 11 0.11 57.86 INTERSTITIAL LUNG DISEASE | 16 0.16 58.02 INTERVERTEBRAL DISC PROTRUSION | 3 0.03 58.05 INTERVERTEBRAL DISCITIS | 2 0.02 58.07 INTESTINAL FUNCTIONAL DISORDER | 1 0.01 58.08 INTESTINAL OBSTRUCTION | 6 0.06 58.14 INTESTINAL PERFORATION | 2 0.02 58.16 INTRA-ABDOMINAL HAEMORRHAGE | 1 0.01 58.17 INTRA-UTERINE CONTRACEPTIVE DEVICE EX.. | 25 0.25 58.42 INTRA-UTERINE CONTRACEPTIVE DEVICE RE.. | 1 0.01 58.43 INTRA-UTERINE DEATH | 2 0.02 58.45 INTRACRANIAL ANEURYSM | 6 0.06 58.51 INTRACRANIAL PRESSURE INCREASED | 5 0.05 58.56 INTRAOCULAR PRESSURE INCREASED | 5 0.05 58.61 INTRAOCULAR PRESSURE TEST ABNORMAL | 1 0.01 58.62 INTRAVASCULAR HAEMOLYSIS | 1 0.01 58.63 INTUSSUSCEPTION | 1 0.01 58.64 IRITIS | 1 0.01 58.65 IRON DEFICIENCY ANAEMIA | 6 0.06 58.71 IRRITABILITY | 18 0.18 58.89 IRRITABLE BOWEL SYNDROME | 6 0.06 58.95 ISCHAEMIC STROKE | 2 0.02 58.97 IUCD COMPLICATION | 5 0.05 59.02 IUD MIGRATION | 2 0.02 59.04 JAUNDICE | 12 0.12 59.16 JAUNDICE CHOLESTATIC | 1 0.01 59.17 JAUNDICE NEONATAL | 2 0.02 59.19 JAW DISORDER | 1 0.01 59.20 JAW FRACTURE | 1 0.01 59.21 JAW OPERATION | 1 0.01 59.22 JEJUNAL ULCER | 1 0.01 59.23 JOB DISSATISFACTION | 1 0.01 59.24 JOINT DISLOCATION | 4 0.04 59.28 JOINT SURGERY | 1 0.01 59.29 JOINT SWELLING | 4 0.04 59.33 KAPOSI'S SARCOMA | 1 0.01 59.34 KIDNEY INFECTION | 1 0.01 59.35 KIDNEY SMALL | 1 0.01 59.36 KNEE ARTHROPLASTY | 2 0.02 59.38 KNEE OPERATION | 1 0.01 59.39 KYPHOSCOLIOSIS | 1 0.01 59.40 LABILE BLOOD PRESSURE | 1 0.01 59.41 LABORATORY TEST ABNORMAL | 1 0.01 59.42 LACERATION | 1 0.01 59.43 LACRIMATION INCREASED | 3 0.03 59.46 LACTIC ACIDOSIS | 9 0.09 59.55 LACTOSE INTOLERANCE | 1 0.01 59.56 LACUNAR INFARCTION | 1 0.01 59.57 LARYNGEAL OEDEMA | 3 0.03 59.60 LARYNGITIS | 1 0.01 59.61 LARYNGOMALACIA | 1 0.01 59.62 LARYNGOSPASM | 6 0.06 59.68 LEFT VENTRICULAR DYSFUNCTION | 1 0.01 59.69 LEFT VENTRICULAR HEAVE | 1 0.01 59.70 LEG AMPUTATION | 2 0.02 59.72 LENS DISORDER | 1 0.01 59.73 LETHARGY | 16 0.16 59.89 LEUKAEMIA | 2 0.02 59.91 LEUKAEMIA RECURRENT | 1 0.01 59.92 LEUKOCYTOSIS | 5 0.05 59.97 LEUKOENCEPHALOMYELITIS | 1 0.01 59.98 LEUKOPENIA | 8 0.08 60.06 LIBIDO DECREASED | 3 0.03 60.09 LIBIDO INCREASED | 1 0.01 60.10 LIMB DISCOMFORT | 1 0.01 60.11 LIMB INJURY | 1 0.01 60.12 LIMB MALFORMATION | 1 0.01 60.13 LIMB OPERATION | 1 0.01 60.14 LIP DISCOLOURATION | 1 0.01 60.15 LIP DISORDER | 2 0.02 60.17 LIP DRY | 10 0.10 60.27 LIP EROSION | 3 0.03 60.30 LIP SWELLING | 13 0.13 60.43 LIPASE INCREASED | 3 0.03 60.46 LIPOMA | 2 0.02 60.48 LISTLESS | 1 0.01 60.49 LIVE BIRTH | 2 0.02 60.51 LIVER DISORDER | 17 0.17 60.68 LIVER FUNCTION TEST ABNORMAL | 15 0.15 60.83 LIVER INJURY | 1 0.01 60.84 LOBAR PNEUMONIA | 2 0.02 60.86 LOCAL SWELLING | 1 0.01 60.87 LOCALISED OEDEMA | 2 0.02 60.89 LOSS OF CONSCIOUSNESS | 39 0.39 61.28 LOSS OF DREAMING | 1 0.01 61.29 LOSS OF LIBIDO | 1 0.01 61.30 LOW DENSITY LIPOPROTEIN INCREASED | 1 0.01 61.31 LOWER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 61.32 LOWER LIMB FRACTURE | 1 0.01 61.33 LOWER RESPIRATORY TRACT INFECTION | 6 0.06 61.39 LOWER RESPIRATORY TRACT INFECTION FUN.. | 1 0.01 61.40 LUMBAR SPINAL STENOSIS | 2 0.02 61.42 LUNG ABSCESS | 1 0.01 61.43 LUNG CANCER METASTATIC | 1 0.01 61.44 LUNG DISORDER | 7 0.07 61.51 LUNG HYPERINFLATION | 1 0.01 61.52 LUNG INFECTION | 3 0.03 61.55 LUNG INFECTION PSEUDOMONAL | 1 0.01 61.56 LUNG INFILTRATION | 8 0.08 61.64 LUNG INJURY | 4 0.04 61.68 LUNG NEOPLASM MALIGNANT | 3 0.03 61.71 LUPUS-LIKE SYNDROME | 3 0.03 61.74 LYME DISEASE | 1 0.01 61.75 LYMPH NODE PAIN | 2 0.02 61.77 LYMPHADENITIS | 1 0.01 61.78 LYMPHADENOPATHY | 10 0.10 61.88 LYMPHOCYTE COUNT DECREASED | 3 0.03 61.91 LYMPHOCYTE PERCENTAGE DECREASED | 1 0.01 61.92 LYMPHOMA | 1 0.01 61.93 LYMPHOPENIA | 2 0.02 61.95 MACULAR HOLE | 1 0.01 61.96 MACULAR OEDEMA | 1 0.01 61.97 MACULOPATHY | 2 0.02 61.99 MADAROSIS | 2 0.02 62.01 MAJOR DEPRESSION | 2 0.02 62.03 MALABSORPTION | 1 0.01 62.04 MALAISE | 39 0.39 62.43 MALARIA | 1 0.01 62.44 MALIGNANT ASCITES | 2 0.02 62.46 MALIGNANT MELANOMA | 1 0.01 62.47 MALIGNANT NEOPLASM PROGRESSION | 12 0.12 62.59 MALIGNANT PLEURAL EFFUSION | 1 0.01 62.60 MALNUTRITION | 4 0.04 62.64 MAMMOGRAM ABNORMAL | 2 0.02 62.66 MANIA | 9 0.09 62.75 MASS | 4 0.04 62.79 MASTECTOMY | 1 0.01 62.80 MASTICATION DISORDER | 3 0.03 62.83 MATERNAL CONDITION AFFECTING FOETUS | 1 0.01 62.84 MATERNAL DRUGS AFFECTING FOETUS | 1 0.01 62.85 MEAN CELL HAEMOGLOBIN CONCENTRATION | 1 0.01 62.86 MEAN CELL HAEMOGLOBIN CONCENTRATION I.. | 1 0.01 62.87 MEAN CELL VOLUME DECREASED | 2 0.02 62.89 MECHANICAL VENTILATION | 3 0.03 62.92 MEDICAL DEVICE COMPLICATION | 1 0.01 62.93 MEDICATION ERROR | 8 0.08 63.01 MEDICATION TAMPERING | 1 0.01 63.02 MELAENA | 5 0.05 63.07 MELANOCYTIC NAEVUS | 1 0.01 63.08 MEMORY IMPAIRMENT | 18 0.18 63.26 MENINGEAL DISORDER | 1 0.01 63.27 MENINGITIS | 1 0.01 63.28 MENINGITIS ASEPTIC | 5 0.05 63.33 MENINGITIS BACTERIAL | 1 0.01 63.34 MENINGOCOCCAL INFECTION | 1 0.01 63.35 MENINGOMYELOCELE | 1 0.01 63.36 MENINGORRHAGIA | 1 0.01 63.37 MENISCUS LESION | 1 0.01 63.38 MENORRHAGIA | 2 0.02 63.40 MENSTRUAL DISORDER | 3 0.03 63.43 MENSTRUATION IRREGULAR | 2 0.02 63.45 MENTAL DISORDER | 12 0.12 63.57 MENTAL IMPAIRMENT | 2 0.02 63.59 MENTAL STATUS CHANGES | 5 0.05 63.64 MESENTERIC ARTERY STENOSIS | 1 0.01 63.65 MESENTERIC OCCLUSION | 1 0.01 63.66 METABOLIC ACIDOSIS | 6 0.06 63.72 METABOLIC DISORDER | 1 0.01 63.73 METASTASES TO BONE | 3 0.03 63.76 METASTASES TO CENTRAL NERVOUS SYSTEM | 4 0.04 63.80 METASTASES TO CHEST WALL | 1 0.01 63.81 METASTASES TO GASTROINTESTINAL TRACT | 1 0.01 63.82 METASTASES TO LUNG | 2 0.02 63.84 METASTASIS | 1 0.01 63.85 METASTATIC MALIGNANT MELANOMA | 1 0.01 63.86 METASTATIC NEOPLASM | 2 0.02 63.88 METRORRHAGIA | 5 0.05 63.93 MICROGNATHIA | 1 0.01 63.94 MICTURITION DISORDER | 1 0.01 63.95 MICTURITION URGENCY | 1 0.01 63.96 MIDDLE EAR EFFUSION | 1 0.01 63.97 MIDDLE INSOMNIA | 57 0.57 64.54 MIGRAINE | 10 0.10 64.64 MIOSIS | 5 0.05 64.69 MITOCHONDRIAL TOXICITY | 1 0.01 64.70 MITRAL VALVE DISEASE | 1 0.01 64.71 MITRAL VALVE INCOMPETENCE | 1 0.01 64.72 MITRAL VALVE PROLAPSE | 1 0.01 64.73 MOBILITY DECREASED | 3 0.03 64.76 MONARTHRITIS | 2 0.02 64.78 MONOCYTE COUNT INCREASED | 1 0.01 64.79 MONOCYTE PERCENTAGE INCREASED | 1 0.01 64.80 MONOPLEGIA | 1 0.01 64.81 MOOD ALTERED | 14 0.14 64.95 MOOD SWINGS | 10 0.10 65.05 MOUTH HAEMORRHAGE | 2 0.02 65.07 MOUTH ULCERATION | 11 0.11 65.18 MOVEMENT DISORDER | 5 0.05 65.23 MUCOCUTANEOUS RASH | 1 0.01 65.24 MUCOSAL EROSION | 2 0.02 65.26 MUCOSAL INFLAMMATION | 13 0.13 65.39 MUCOUS MEMBRANE DISORDER | 1 0.01 65.40 MULTI-ORGAN FAILURE | 16 0.16 65.56 MULTIPLE CONGENITAL ABNORMALITIES | 1 0.01 65.57 MULTIPLE DRUG OVERDOSE ACCIDENTAL | 1 0.01 65.58 MULTIPLE DRUG OVERDOSE INTENTIONAL | 1 0.01 65.59 MULTIPLE MYELOMA | 2 0.02 65.61 MULTIPLE SCLEROSIS | 2 0.02 65.63 MULTIPLE SCLEROSIS RELAPSE | 1 0.01 65.64 MUSCLE ATROPHY | 3 0.03 65.67 MUSCLE CONTRACTURE | 1 0.01 65.68 MUSCLE DISORDER | 5 0.05 65.73 MUSCLE FLAP OPERATION | 1 0.01 65.74 MUSCLE INJURY | 2 0.02 65.76 MUSCLE RIGIDITY | 1 0.01 65.77 MUSCLE SPASMS | 16 0.16 65.93 MUSCLE SPASTICITY | 1 0.01 65.94 MUSCLE TWITCHING | 6 0.06 66.00 MUSCULAR WEAKNESS | 22 0.22 66.22 MUSCULOSKELETAL CHEST PAIN | 6 0.06 66.28 MUSCULOSKELETAL DISCOMFORT | 1 0.01 66.29 MUSCULOSKELETAL DISORDER | 1 0.01 66.30 MUSCULOSKELETAL PAIN | 8 0.08 66.38 MUSCULOSKELETAL STIFFNESS | 9 0.09 66.47 MYALGIA | 34 0.34 66.81 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 1 0.01 66.82 MYCOBACTERIUM CHELONEI INFECTION | 1 0.01 66.83 MYCOPLASMA INFECTION | 1 0.01 66.84 MYDRIASIS | 2 0.02 66.86 MYELODYSPLASTIC SYNDROME | 5 0.05 66.91 MYOCARDIAL INFARCTION | 69 0.69 67.60 MYOCARDIAL ISCHAEMIA | 4 0.04 67.64 MYOCARDIAL OEDEMA | 1 0.01 67.65 MYOCARDITIS | 2 0.02 67.67 MYOCLONIC EPILEPSY | 1 0.01 67.68 MYOCLONUS | 2 0.02 67.70 MYOGLOBIN BLOOD INCREASED | 1 0.01 67.71 MYOGLOBIN URINE PRESENT | 1 0.01 67.72 MYOGLOBINURIA | 1 0.01 67.73 MYOPATHY | 4 0.04 67.77 MYOSITIS | 3 0.03 67.80 NAIL DISORDER | 1 0.01 67.81 NASAL CONGESTION | 5 0.05 67.86 NASAL DISCOMFORT | 2 0.02 67.88 NASAL DISORDER | 1 0.01 67.89 NASAL INFLAMMATION | 1 0.01 67.90 NASOPHARYNGITIS | 7 0.07 67.97 NAUSEA | 151 1.51 69.48 NECK INJURY | 1 0.01 69.49 NECK MASS | 1 0.01 69.50 NECK PAIN | 13 0.13 69.63 NECROSIS | 3 0.03 69.66 NECROTISING FASCIITIS | 1 0.01 69.67 NEGATIVE THOUGHTS | 1 0.01 69.68 NEONATAL PNEUMONIA | 1 0.01 69.69 NEONATAL RESPIRATORY DISTRESS SYNDROME | 2 0.02 69.71 NEOPLASM | 1 0.01 69.72 NEOPLASM MALIGNANT | 4 0.04 69.76 NEPHRITIS | 1 0.01 69.77 NEPHRITIS INTERSTITIAL | 2 0.02 69.79 NEPHROGENIC SYSTEMIC FIBROSIS | 2 0.02 69.81 NEPHROLITHIASIS | 3 0.03 69.84 NEPHROPATHY | 1 0.01 69.85 NEPHROPATHY TOXIC | 2 0.02 69.87 NEPHROSCLEROSIS | 2 0.02 69.89 NEPHROTIC SYNDROME | 4 0.04 69.93 NERVE INJURY | 2 0.02 69.95 NERVOUS SYSTEM DISORDER | 3 0.03 69.98 NERVOUSNESS | 8 0.08 70.06 NEURALGIA | 2 0.02 70.08 NEUROBLASTOMA | 1 0.01 70.09 NEUROGENIC BLADDER | 1 0.01 70.10 NEUROLEPTIC MALIGNANT SYNDROME | 2 0.02 70.12 NEUROPATHY PERIPHERAL | 9 0.09 70.21 NEUROSIS | 1 0.01 70.22 NEUROTOXICITY | 2 0.02 70.24 NEUTROPENIA | 29 0.29 70.53 NEUTROPENIC SEPSIS | 2 0.02 70.55 NEUTROPHIL COUNT ABNORMAL | 1 0.01 70.56 NEUTROPHIL COUNT DECREASED | 3 0.03 70.59 NEUTROPHIL PERCENTAGE INCREASED | 1 0.01 70.60 NICOTINE DEPENDENCE | 2 0.02 70.62 NIGHT BLINDNESS | 1 0.01 70.63 NIGHT SWEATS | 3 0.03 70.66 NIGHTMARE | 19 0.19 70.85 NIPPLE EXUDATE BLOODY | 1 0.01 70.86 NO ADVERSE EVENT | 19 0.19 71.05 NO THERAPEUTIC RESPONSE | 5 0.05 71.10 NOCARDIA SEPSIS | 1 0.01 71.11 NOCTURIA | 1 0.01 71.12 NOCTURNAL DYSPNOEA | 2 0.02 71.14 NON-CARDIAC CHEST PAIN | 1 0.01 71.15 NON-HODGKIN'S LYMPHOMA | 2 0.02 71.17 NOONAN SYNDROME | 2 0.02 71.19 NORMAL NEWBORN | 1 0.01 71.20 NOSE DEFORMITY | 1 0.01 71.21 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 2 0.02 71.23 NYSTAGMUS | 3 0.03 71.26 OBESITY | 3 0.03 71.29 OBESITY SURGERY | 1 0.01 71.30 OBSESSIVE THOUGHTS | 1 0.01 71.31 OBSESSIVE-COMPULSIVE DISORDER | 1 0.01 71.32 OBSTRUCTIVE AIRWAYS DISORDER | 1 0.01 71.33 OCULAR HYPERAEMIA | 5 0.05 71.38 OCULAR ICTERUS | 3 0.03 71.41 OCULAR VASCULAR DISORDER | 2 0.02 71.43 ODONTOGENIC CYST | 1 0.01 71.44 ODYNOPHAGIA | 1 0.01 71.45 OEDEMA | 11 0.11 71.56 OEDEMA GENITAL | 1 0.01 71.57 OEDEMA MOUTH | 2 0.02 71.59 OEDEMA PERIPHERAL | 37 0.37 71.96 OESOPHAGEAL CANDIDIASIS | 3 0.03 71.99 OESOPHAGEAL DISCOMFORT | 1 0.01 72.00 OESOPHAGEAL DISORDER | 1 0.01 72.01 OESOPHAGEAL HAEMORRHAGE | 1 0.01 72.02 OESOPHAGEAL VARICES HAEMORRHAGE | 1 0.01 72.03 OESOPHAGITIS | 3 0.03 72.06 OESTRADIOL INCREASED | 1 0.01 72.07 OFF LABEL USE | 8 0.08 72.15 OLIGURIA | 3 0.03 72.18 ON AND OFF PHENOMENON | 1 0.01 72.19 ONYCHOMYCOSIS | 2 0.02 72.21 OPEN ANGLE GLAUCOMA | 1 0.01 72.22 OPEN FRACTURE | 1 0.01 72.23 OPEN WOUND | 2 0.02 72.25 OPIATES | 1 0.01 72.26 OPPOSITIONAL DEFIANT DISORDER | 2 0.02 72.28 OPTIC ATROPHY | 1 0.01 72.29 OPTIC NERVE HYPOPLASIA | 1 0.01 72.30 OPTIC NEURITIS | 1 0.01 72.31 ORAL DISCOMFORT | 1 0.01 72.32 ORAL DISORDER | 3 0.03 72.35 ORAL FIBROMA | 1 0.01 72.36 ORAL HERPES | 3 0.03 72.39 ORAL INFECTION | 1 0.01 72.40 ORAL INTAKE REDUCED | 10 0.10 72.50 ORAL MUCOSA EROSION | 1 0.01 72.51 ORAL PAIN | 4 0.04 72.55 ORAL TORUS | 1 0.01 72.56 ORGASM ABNORMAL | 1 0.01 72.57 ORTHOSTATIC HYPOTENSION | 2 0.02 72.59 OSTEITIS | 1 0.01 72.60 OSTEITIS DEFORMANS | 2 0.02 72.62 OSTEOARTHRITIS | 6 0.06 72.68 OSTEOCHONDROMA | 1 0.01 72.69 OSTEOMYELITIS | 10 0.10 72.79 OSTEONECROSIS | 23 0.23 73.02 OSTEOPOROSIS | 3 0.03 73.05 OSTEORADIONECROSIS | 1 0.01 73.06 OSTEOSYNTHESIS | 1 0.01 73.07 OVARIAN CANCER METASTATIC | 2 0.02 73.09 OVARIAN CYST | 3 0.03 73.12 OVARIAN HYPERSTIMULATION SYNDROME | 1 0.01 73.13 OVERDOSE | 45 0.45 73.58 OXYGEN CONSUMPTION INCREASED | 1 0.01 73.59 OXYGEN SATURATION ABNORMAL | 1 0.01 73.60 OXYGEN SATURATION DECREASED | 13 0.13 73.73 PAGET'S DISEASE OF THE BREAST | 1 0.01 73.74 PAIN | 46 0.46 74.20 PAIN IN EXTREMITY | 41 0.41 74.61 PAIN IN JAW | 6 0.06 74.67 PAIN MANAGEMENT | 2 0.02 74.69 PAIN OF SKIN | 1 0.01 74.70 PAINFUL DEFAECATION | 1 0.01 74.71 PALLOR | 10 0.10 74.81 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 1 0.01 74.82 PALPABLE PURPURA | 1 0.01 74.83 PALPITATIONS | 24 0.24 75.07 PANCREATIC CARCINOMA | 1 0.01 75.08 PANCREATIC CARCINOMA RECURRENT | 1 0.01 75.09 PANCREATIC DUCT STENOSIS | 1 0.01 75.10 PANCREATITIS | 12 0.12 75.22 PANCREATITIS ACUTE | 6 0.06 75.28 PANCREATITIS RELAPSING | 1 0.01 75.29 PANCYTOPENIA | 12 0.12 75.41 PANIC ATTACK | 10 0.10 75.51 PANIC DISORDER | 1 0.01 75.52 PANIC REACTION | 3 0.03 75.55 PAPILLOEDEMA | 6 0.06 75.61 PARADOXICAL DRUG REACTION | 3 0.03 75.64 PARADOXICAL EMBOLISM | 1 0.01 75.65 PARAESTHESIA | 17 0.17 75.82 PARAESTHESIA ORAL | 3 0.03 75.85 PARALYSIS | 5 0.05 75.90 PARANEOPLASTIC SYNDROME | 1 0.01 75.91 PARANOIA | 6 0.06 75.97 PARKINSON'S DISEASE | 4 0.04 76.01 PARKINSONISM | 2 0.02 76.03 PARONYCHIA | 1 0.01 76.04 PAROSMIA | 4 0.04 76.08 PAROTITIS | 1 0.01 76.09 PARTIAL SEIZURES | 1 0.01 76.10 PATENT DUCTUS ARTERIOSUS | 5 0.05 76.15 PELVIC FRACTURE | 1 0.01 76.16 PEMPHIGOID | 1 0.01 76.17 PENIS DISORDER | 1 0.01 76.18 PEPTIC ULCER | 2 0.02 76.20 PEPTIC ULCER HAEMORRHAGE | 2 0.02 76.22 PERIANAL ABSCESS | 1 0.01 76.23 PERICARDIAL EFFUSION | 2 0.02 76.25 PERICARDITIS | 2 0.02 76.27 PERICORONITIS | 1 0.01 76.28 PERINEAL ABSCESS | 1 0.01 76.29 PERIORBITAL OEDEMA | 2 0.02 76.31 PERIOSTITIS | 1 0.01 76.32 PERIPHERAL COLDNESS | 1 0.01 76.33 PERIPHERAL EMBOLISM | 2 0.02 76.35 PERIPHERAL SENSORY NEUROPATHY | 1 0.01 76.36 PERIPHERAL VASCULAR DISORDER | 1 0.01 76.37 PERIRECTAL ABSCESS | 1 0.01 76.38 PERITONEAL HAEMORRHAGE | 1 0.01 76.39 PERITONITIS | 3 0.03 76.42 PERITONITIS BACTERIAL | 1 0.01 76.43 PERITONSILLAR ABSCESS | 1 0.01 76.44 PERSECUTORY DELUSION | 1 0.01 76.45 PERSISTENT FOETAL CIRCULATION | 7 0.07 76.52 PERSONALITY CHANGE | 6 0.06 76.58 PETECHIAE | 2 0.02 76.60 PHARMACEUTICAL PRODUCT COMPLAINT | 47 0.47 77.07 PHARMACEUTICAL PRODUCT COUNTERFEIT | 1 0.01 77.08 PHARYNGEAL ERYTHEMA | 1 0.01 77.09 PHARYNGEAL OEDEMA | 9 0.09 77.18 PHARYNGITIS | 1 0.01 77.19 PHARYNGOLARYNGEAL PAIN | 2 0.02 77.21 PHOTOONYCHOLYSIS | 1 0.01 77.22 PHOTOPHOBIA | 2 0.02 77.24 PHOTOPSIA | 2 0.02 77.26 PHOTOSENSITIVITY REACTION | 2 0.02 77.28 PHYSICAL DISABILITY | 1 0.01 77.29 PICA | 1 0.01 77.30 PIGMENTATION DISORDER | 2 0.02 77.32 PILOERECTION | 1 0.01 77.33 PITUITARY HAEMORRHAGE | 1 0.01 77.34 PITUITARY TUMOUR BENIGN | 2 0.02 77.36 PLACENTAL DISORDER | 1 0.01 77.37 PLATELET COUNT ABNORMAL | 3 0.03 77.40 PLATELET COUNT DECREASED | 24 0.24 77.64 PLATELET COUNT INCREASED | 2 0.02 77.66 PLEURAL DISORDER | 1 0.01 77.67 PLEURAL EFFUSION | 12 0.12 77.79 PLEURISY | 2 0.02 77.81 PLEURITIC PAIN | 1 0.01 77.82 PNEUMATOSIS INTESTINALIS | 2 0.02 77.84 PNEUMOCYSTIS JIROVECI PNEUMONIA | 8 0.08 77.92 PNEUMONIA | 44 0.44 78.36 PNEUMONIA ASPIRATION | 6 0.06 78.42 PNEUMONIA BACTERIAL | 2 0.02 78.44 PNEUMONIA FUNGAL | 1 0.01 78.45 PNEUMONIA KLEBSIELLA | 1 0.01 78.46 PNEUMONIA LEGIONELLA | 2 0.02 78.48 PNEUMONIA PRIMARY ATYPICAL | 1 0.01 78.49 PNEUMONITIS | 5 0.05 78.54 PNEUMOTHORAX | 1 0.01 78.55 POISONING | 1 0.01 78.56 POLLAKIURIA | 10 0.10 78.66 POLYDIPSIA | 2 0.02 78.68 POLYHYDRAMNIOS | 1 0.01 78.69 POLYMYALGIA RHEUMATICA | 1 0.01 78.70 POLYNEUROPATHY | 2 0.02 78.72 POLYP | 4 0.04 78.76 POLYPECTOMY | 1 0.01 78.77 POLYURIA | 5 0.05 78.82 POOR PERSONAL HYGIENE | 1 0.01 78.83 POOR QUALITY SLEEP | 16 0.16 78.99 PORENCEPHALY | 1 0.01 79.00 PORTAL VEIN THROMBOSIS | 3 0.03 79.03 POST PROCEDURAL COMPLICATION | 3 0.03 79.06 POST PROCEDURAL HAEMORRHAGE | 3 0.03 79.09 POST PROCEDURAL INFECTION | 1 0.01 79.10 POST-TRAUMATIC STRESS DISORDER | 1 0.01 79.11 POSTNASAL DRIP | 1 0.01 79.12 POSTOPERATIVE ABSCESS | 1 0.01 79.13 POSTOPERATIVE WOUND INFECTION | 2 0.02 79.15 POSTURE ABNORMAL | 1 0.01 79.16 POUCHITIS | 2 0.02 79.18 POVERTY OF SPEECH | 1 0.01 79.19 PRE-ECLAMPSIA | 1 0.01 79.20 PRECANCEROUS CELLS PRESENT | 1 0.01 79.21 PREGNANCY | 28 0.28 79.49 PREGNANCY OF PARTNER | 2 0.02 79.51 PREGNANCY ON ORAL CONTRACEPTIVE | 1 0.01 79.52 PREGNANCY TEST POSITIVE | 1 0.01 79.53 PREGNANCY WITH CONTRACEPTIVE DEVICE | 4 0.04 79.57 PREGNANCY WITH CONTRACEPTIVE PATCH | 1 0.01 79.58 PREMATURE BABY | 8 0.08 79.66 PREMATURE LABOUR | 1 0.01 79.67 PREMATURE RUPTURE OF MEMBRANES | 1 0.01 79.68 PREMENSTRUAL SYNDROME | 1 0.01 79.69 PRESYNCOPE | 8 0.08 79.77 PRIAPISM | 2 0.02 79.79 PRIMARY SEQUESTRUM | 2 0.02 79.81 PROCEDURAL COMPLICATION | 2 0.02 79.83 PROCEDURAL PAIN | 6 0.06 79.89 PROCEDURAL VOMITING | 1 0.01 79.90 PROCTALGIA | 2 0.02 79.92 PROCTITIS | 5 0.05 79.97 PROCTITIS ULCERATIVE | 2 0.02 79.99 PRODUCTIVE COUGH | 1 0.01 80.00 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALO.. | 3 0.03 80.03 PROMINENT EPICANTHAL FOLDS | 1 0.01 80.04 PROSTATE CANCER | 4 0.04 80.08 PROSTATE INFECTION | 1 0.01 80.09 PROSTATIC OPERATION | 1 0.01 80.10 PROSTATIC SPECIFIC ANTIGEN INCREASED | 1 0.01 80.11 PROSTATITIS | 1 0.01 80.12 PROSTATOMEGALY | 2 0.02 80.14 PROTEIN TOTAL DECREASED | 1 0.01 80.15 PROTEIN URINE PRESENT | 1 0.01 80.16 PROTEINURIA | 5 0.05 80.21 PROTHROMBIN LEVEL ABNORMAL | 1 0.01 80.22 PROTHROMBIN TIME PROLONGED | 1 0.01 80.23 PRURITUS | 47 0.47 80.70 PRURITUS GENERALISED | 9 0.09 80.79 PSEUDOMONAL BACTERAEMIA | 1 0.01 80.80 PSEUDOMONAS INFECTION | 1 0.01 80.81 PSORIASIS | 2 0.02 80.83 PSYCHIATRIC SYMPTOM | 2 0.02 80.85 PSYCHOMOTOR HYPERACTIVITY | 3 0.03 80.88 PSYCHOMOTOR SKILLS IMPAIRED | 2 0.02 80.90 PSYCHOTIC DISORDER | 7 0.07 80.97 PULMONARY ARTERY STENOSIS | 1 0.01 80.98 PULMONARY ARTERY THROMBOSIS | 3 0.03 81.01 PULMONARY CAVITATION | 2 0.02 81.03 PULMONARY CONGESTION | 1 0.01 81.04 PULMONARY EMBOLISM | 19 0.19 81.23 PULMONARY FIBROSIS | 4 0.04 81.27 PULMONARY GRANULOMA | 1 0.01 81.28 PULMONARY HYPERTENSION | 4 0.04 81.32 PULMONARY HYPOPLASIA | 1 0.01 81.33 PULMONARY MALFORMATION | 1 0.01 81.34 PULMONARY MASS | 2 0.02 81.36 PULMONARY OEDEMA | 10 0.10 81.46 PULMONARY SEPSIS | 1 0.01 81.47 PULMONARY THROMBOSIS | 1 0.01 81.48 PULMONARY TOXICITY | 7 0.07 81.55 PULMONARY TUBERCULOSIS | 2 0.02 81.57 PULMONARY VALVE INCOMPETENCE | 1 0.01 81.58 PULMONARY VALVE STENOSIS | 2 0.02 81.60 PULMONARY VALVE STENOSIS CONGENITAL | 1 0.01 81.61 PULSE ABSENT | 3 0.03 81.64 PUPILLARY REFLEX IMPAIRED | 2 0.02 81.66 PURPURA | 4 0.04 81.70 PYELOCALIECTASIS | 1 0.01 81.71 PYELONEPHRITIS | 1 0.01 81.72 PYLORIC STENOSIS | 1 0.01 81.73 PYREXIA | 70 0.70 82.43 QUADRIPLEGIA | 1 0.01 82.44 RADIATION PERICARDITIS | 1 0.01 82.45 RADIATION PNEUMONITIS | 1 0.01 82.46 RADIATION SKIN INJURY | 1 0.01 82.47 RADIOTHERAPY | 1 0.01 82.48 RADIUS FRACTURE | 1 0.01 82.49 RALES | 2 0.02 82.51 RASH | 67 0.67 83.18 RASH ERYTHEMATOUS | 8 0.08 83.26 RASH GENERALISED | 16 0.16 83.42 RASH MACULAR | 2 0.02 83.44 RASH MACULO-PAPULAR | 5 0.05 83.49 RASH MORBILLIFORM | 1 0.01 83.50 RASH PAPULAR | 3 0.03 83.53 RASH PRURITIC | 5 0.05 83.58 RASH PUSTULAR | 1 0.01 83.59 RASH VESICULAR | 1 0.01 83.60 READING DISORDER | 1 0.01 83.61 RECALL PHENOMENON | 3 0.03 83.64 RECTAL DISCHARGE | 1 0.01 83.65 RECTAL HAEMORRHAGE | 9 0.09 83.74 RECTAL TENESMUS | 1 0.01 83.75 RECTAL ULCER | 1 0.01 83.76 RECTOCELE | 1 0.01 83.77 RED BLOOD CELL COUNT DECREASED | 5 0.05 83.82 RED BLOOD CELL COUNT INCREASED | 1 0.01 83.83 RED BLOOD CELL SCHISTOCYTES PRESENT | 1 0.01 83.84 RED BLOOD CELL SEDIMENTATION RATE INC.. | 4 0.04 83.88 REFLUX GASTRITIS | 1 0.01 83.89 REFLUX OESOPHAGITIS | 1 0.01 83.90 REMOVAL OF RENAL TRANSPLANT | 1 0.01 83.91 RENAL ARTERY DISSECTION | 1 0.01 83.92 RENAL ARTERY STENOSIS | 1 0.01 83.93 RENAL CYST | 1 0.01 83.94 RENAL DISORDER | 8 0.08 84.02 RENAL DYSPLASIA | 1 0.01 84.03 RENAL FAILURE | 40 0.40 84.43 RENAL FAILURE ACUTE | 41 0.41 84.84 RENAL FAILURE CHRONIC | 7 0.07 84.91 RENAL FUNCTION TEST ABNORMAL | 2 0.02 84.93 RENAL IMPAIRMENT | 8 0.08 85.01 RENAL INFARCT | 1 0.01 85.02 RENAL INJURY | 3 0.03 85.05 RENAL PAIN | 1 0.01 85.06 RENAL TRANSPLANT | 1 0.01 85.07 RENAL TUBULAR DISORDER | 1 0.01 85.08 RENAL TUBULAR NECROSIS | 5 0.05 85.13 RENAL VESSEL DISORDER | 1 0.01 85.14 REPETITIVE SPEECH | 1 0.01 85.15 RESORPTION BONE INCREASED | 4 0.04 85.19 RESPIRATORY ARREST | 10 0.10 85.29 RESPIRATORY DEPRESSION | 7 0.07 85.36 RESPIRATORY DISORDER | 8 0.08 85.44 RESPIRATORY DISTRESS | 8 0.08 85.52 RESPIRATORY FAILURE | 21 0.21 85.73 RESPIRATORY RATE DECREASED | 1 0.01 85.74 RESPIRATORY RATE INCREASED | 3 0.03 85.77 RESPIRATORY SIGHS | 1 0.01 85.78 RESPIRATORY TRACT INFECTION | 1 0.01 85.79 RESPITE CARE | 1 0.01 85.80 RESTLESS LEGS SYNDROME | 1 0.01 85.81 RESTLESSNESS | 14 0.14 85.95 RETCHING | 3 0.03 85.98 RETINAL DEGENERATION | 1 0.01 85.99 RETINAL DETACHMENT | 7 0.07 86.06 RETINAL DISORDER | 1 0.01 86.07 RETINAL EXUDATES | 1 0.01 86.08 RETINAL HAEMORRHAGE | 1 0.01 86.09 RETINAL ISCHAEMIA | 1 0.01 86.10 RETINAL NEOVASCULARISATION | 1 0.01 86.11 RETINOPATHY | 3 0.03 86.14 RETINOPATHY PROLIFERATIVE | 1 0.01 86.15 RETROGNATHIA | 1 0.01 86.16 RETROPERITONEAL HAEMORRHAGE | 2 0.02 86.18 REVERSIBLE POSTERIOR LEUKOENCEPHALOPA.. | 2 0.02 86.20 REYE'S SYNDROME | 1 0.01 86.21 RHABDOMYOLYSIS | 38 0.38 86.59 RHEUMATOID ARTHRITIS | 6 0.06 86.65 RHEUMATOID NODULE | 1 0.01 86.66 RHINITIS | 1 0.01 86.67 RHINORRHOEA | 6 0.06 86.73 RIB FRACTURE | 4 0.04 86.77 RIGHT ATRIAL DILATATION | 1 0.01 86.78 RIGHT VENTRICLE OUTFLOW TRACT OBSTRUC.. | 1 0.01 86.79 RIGHT VENTRICULAR HYPERTROPHY | 2 0.02 86.81 ROAD TRAFFIC ACCIDENT | 9 0.09 86.90 SACROILIITIS | 3 0.03 86.93 SCAB | 1 0.01 86.94 SCAR | 5 0.05 86.99 SCHIZOPHRENIA | 2 0.02 87.01 SCOLIOSIS | 5 0.05 87.06 SCREAMING | 3 0.03 87.09 SEASONAL ALLERGY | 1 0.01 87.10 SEBORRHOEA | 1 0.01 87.11 SECRETION DISCHARGE | 1 0.01 87.12 SEDATION | 5 0.05 87.17 SELF ESTEEM DECREASED | 2 0.02 87.19 SELF INJURIOUS BEHAVIOUR | 1 0.01 87.20 SELF-INJURIOUS IDEATION | 2 0.02 87.22 SENSATION OF FOREIGN BODY | 1 0.01 87.23 SENSATION OF HEAVINESS | 2 0.02 87.25 SENSORY DISTURBANCE | 4 0.04 87.29 SENSORY LOSS | 4 0.04 87.33 SEPSIS | 25 0.25 87.58 SEPSIS NEONATAL | 1 0.01 87.59 SEPSIS SYNDROME | 1 0.01 87.60 SEPTIC SHOCK | 9 0.09 87.69 SEQUESTRECTOMY | 2 0.02 87.71 SEROTONIN SYNDROME | 1 0.01 87.72 SERRATIA INFECTION | 1 0.01 87.73 SERUM FERRITIN ABNORMAL | 1 0.01 87.74 SERUM FERRITIN INCREASED | 2 0.02 87.76 SEX CHROMOSOME ABNORMALITY | 1 0.01 87.77 SEXUAL DYSFUNCTION | 3 0.03 87.80 SHOCK | 9 0.09 87.89 SHOCK HAEMORRHAGIC | 1 0.01 87.90 SICKLE CELL ANAEMIA WITH CRISIS | 1 0.01 87.91 SINGLE UMBILICAL ARTERY | 1 0.01 87.92 SINUS ARRHYTHMIA | 1 0.01 87.93 SINUS BRADYCARDIA | 1 0.01 87.94 SINUS DISORDER | 1 0.01 87.95 SINUS HEADACHE | 1 0.01 87.96 SINUS OPERATION | 1 0.01 87.97 SINUS TACHYCARDIA | 1 0.01 87.98 SINUSITIS | 10 0.10 88.08 SKELETAL INJURY | 1 0.01 88.09 SKIN BURNING SENSATION | 1 0.01 88.10 SKIN DISCOLOURATION | 3 0.03 88.13 SKIN DISORDER | 5 0.05 88.18 SKIN EROSION | 1 0.01 88.19 SKIN EXFOLIATION | 9 0.09 88.28 SKIN INFECTION | 1 0.01 88.29 SKIN IRRITATION | 2 0.02 88.31 SKIN LACERATION | 3 0.03 88.34 SKIN LESION | 2 0.02 88.36 SKIN REACTION | 1 0.01 88.37 SKIN TOXICITY | 2 0.02 88.39 SKIN ULCER | 2 0.02 88.41 SKIN WRINKLING | 1 0.01 88.42 SKULL FRACTURE | 1 0.01 88.43 SKULL MALFORMATION | 2 0.02 88.45 SLEEP APNOEA SYNDROME | 3 0.03 88.48 SLEEP DISORDER | 9 0.09 88.57 SLEEP TERROR | 2 0.02 88.59 SLUGGISHNESS | 3 0.03 88.62 SMALL FOR DATES BABY | 1 0.01 88.63 SMALL INTESTINAL OBSTRUCTION | 3 0.03 88.66 SMALL INTESTINE CARCINOMA | 1 0.01 88.67 SNEEZING | 4 0.04 88.71 SNORING | 2 0.02 88.73 SOCIAL AVOIDANT BEHAVIOUR | 5 0.05 88.78 SOCIAL PHOBIA | 1 0.01 88.79 SOCIAL PROBLEM | 1 0.01 88.80 SOMNAMBULISM | 3 0.03 88.83 SOMNOLENCE | 54 0.54 89.37 SOPOR | 2 0.02 89.39 SPEECH DISORDER | 15 0.15 89.54 SPEECH DISORDER DEVELOPMENTAL | 1 0.01 89.55 SPERMATOGENESIS ABNORMAL | 1 0.01 89.56 SPHINCTER OF ODDI DYSFUNCTION | 1 0.01 89.57 SPINA BIFIDA | 1 0.01 89.58 SPINAL COLUMN STENOSIS | 1 0.01 89.59 SPINAL CORD DISORDER | 1 0.01 89.60 SPINAL DISORDER | 1 0.01 89.61 SPINAL FRACTURE | 1 0.01 89.62 SPINAL LAMINECTOMY | 1 0.01 89.63 SPINAL OSTEOARTHRITIS | 1 0.01 89.64 SPLEEN DISORDER | 1 0.01 89.65 SPLEEN OPERATION | 1 0.01 89.66 SPLENIC INFARCTION | 1 0.01 89.67 SPLENIC RUPTURE | 1 0.01 89.68 SPLENOMEGALY | 2 0.02 89.70 SPOUSAL ABUSE | 1 0.01 89.71 SQUAMOUS CELL CARCINOMA | 3 0.03 89.74 STAG HORN CALCULUS | 1 0.01 89.75 STAPHYLOCOCCAL BACTERAEMIA | 3 0.03 89.78 STAPHYLOCOCCAL INFECTION | 6 0.06 89.84 STAPHYLOCOCCAL SEPSIS | 1 0.01 89.85 STAPHYLOCOCCAL SKIN INFECTION | 1 0.01 89.86 STARING | 1 0.01 89.87 STATUS ASTHMATICUS | 1 0.01 89.88 STATUS EPILEPTICUS | 2 0.02 89.90 STEATORRHOEA | 1 0.01 89.91 STENT PLACEMENT | 7 0.07 89.98 STEVENS-JOHNSON SYNDROME | 14 0.14 90.12 STILLBIRTH | 1 0.01 90.13 STOMACH DISCOMFORT | 10 0.10 90.23 STOMACH MASS | 1 0.01 90.24 STOMATITIS | 6 0.06 90.30 STRABISMUS | 1 0.01 90.31 STRESS | 13 0.13 90.44 STRESS URINARY INCONTINENCE | 1 0.01 90.45 STRIDOR | 1 0.01 90.46 STROKE VOLUME DECREASED | 1 0.01 90.47 SUBCUTANEOUS ABSCESS | 1 0.01 90.48 SUBCUTANEOUS EMPHYSEMA | 2 0.02 90.50 SUBCUTANEOUS NODULE | 1 0.01 90.51 SUBDURAL HAEMATOMA | 1 0.01 90.52 SUBDURAL HAEMORRHAGE | 1 0.01 90.53 SUBSTANCE ABUSE | 2 0.02 90.55 SUDDEN DEATH | 3 0.03 90.58 SUDDEN ONSET OF SLEEP | 1 0.01 90.59 SUICIDAL BEHAVIOUR | 1 0.01 90.60 SUICIDAL IDEATION | 39 0.39 90.99 SUICIDE ATTEMPT | 23 0.23 91.22 SUPERINFECTION | 1 0.01 91.23 SUPRAVENTRICULAR TACHYCARDIA | 3 0.03 91.26 SURGERY | 7 0.07 91.33 SUSPICIOUSNESS | 1 0.01 91.34 SWELLING | 10 0.10 91.44 SWELLING FACE | 16 0.16 91.60 SWOLLEN TONGUE | 7 0.07 91.67 SYNCOPE | 31 0.31 91.98 SYNCOPE VASOVAGAL | 3 0.03 92.01 SYNOVIAL CYST | 1 0.01 92.02 SYNOVITIS | 1 0.01 92.03 SYSTEMIC CANDIDA | 2 0.02 92.05 T-LYMPHOCYTE COUNT INCREASED | 1 0.01 92.06 TACHYCARDIA | 20 0.20 92.26 TACHYPNOEA | 1 0.01 92.27 TALIPES | 2 0.02 92.29 TARDIVE DYSKINESIA | 4 0.04 92.33 TEARFULNESS | 1 0.01 92.34 TEETH BRITTLE | 1 0.01 92.35 TEMPERATURE INTOLERANCE | 1 0.01 92.36 TEMPOROMANDIBULAR JOINT SYNDROME | 1 0.01 92.37 TENDERNESS | 8 0.08 92.45 TENDON CALCIFICATION | 1 0.01 92.46 TENDONITIS | 4 0.04 92.50 TENSION | 1 0.01 92.51 TESTICULAR PAIN | 1 0.01 92.52 THERAPEUTIC AGENT TOXICITY | 2 0.02 92.54 THERAPEUTIC EMBOLISATION | 1 0.01 92.55 THERAPEUTIC PROCEDURE | 1 0.01 92.56 THERAPEUTIC PRODUCT CONTAMINATION | 1 0.01 92.57 THERAPEUTIC PRODUCT INEFFECTIVE | 1 0.01 92.58 THERAPEUTIC RESPONSE DECREASED | 5 0.05 92.63 THERAPEUTIC RESPONSE DELAYED | 1 0.01 92.64 THERAPEUTIC RESPONSE UNEXPECTED | 2 0.02 92.66 THERAPEUTIC RESPONSE UNEXPECTED WITH .. | 3 0.03 92.69 THERAPY RESPONDER | 2 0.02 92.71 THERMAL BURN | 4 0.04 92.75 THINKING ABNORMAL | 10 0.10 92.85 THIRST | 1 0.01 92.86 THOUGHT BLOCKING | 1 0.01 92.87 THREATENED LABOUR | 1 0.01 92.88 THROAT IRRITATION | 9 0.09 92.97 THROAT TIGHTNESS | 10 0.10 93.07 THROMBOCYTOPENIA | 26 0.26 93.33 THROMBOPHLEBITIS | 1 0.01 93.34 THROMBOSIS | 9 0.09 93.43 THROMBOSIS IN DEVICE | 1 0.01 93.44 THROMBOTIC MICROANGIOPATHY | 2 0.02 93.46 THROMBOTIC THROMBOCYTOPENIC PURPURA | 3 0.03 93.49 THYROID NEOPLASM | 2 0.02 93.51 THYROIDITIS | 1 0.01 93.52 THYROXINE INCREASED | 1 0.01 93.53 TINEA CRURIS | 1 0.01 93.54 TINNITUS | 9 0.09 93.63 TOE AMPUTATION | 1 0.01 93.64 TONGUE BITING | 1 0.01 93.65 TONGUE DISCOLOURATION | 1 0.01 93.66 TONGUE DISORDER | 1 0.01 93.67 TONGUE GEOGRAPHIC | 1 0.01 93.68 TONGUE HAEMATOMA | 1 0.01 93.69 TONGUE PARALYSIS | 2 0.02 93.71 TONIC CLONIC MOVEMENTS | 1 0.01 93.72 TOOTH DISCOLOURATION | 1 0.01 93.73 TOOTH DISORDER | 4 0.04 93.77 TOOTH EXTRACTION | 3 0.03 93.80 TOOTH LOSS | 5 0.05 93.85 TORSADE DE POINTES | 2 0.02 93.87 TORTICOLLIS | 2 0.02 93.89 TOXIC ENCEPHALOPATHY | 1 0.01 93.90 TOXIC EPIDERMAL NECROLYSIS | 3 0.03 93.93 TOXIC SKIN ERUPTION | 1 0.01 93.94 TRACHEAL DISORDER | 1 0.01 93.95 TRACHEAL STENOSIS | 1 0.01 93.96 TRACHEAL ULCER | 1 0.01 93.97 TRACHEOMALACIA | 1 0.01 93.98 TRACHEOSTOMY | 2 0.02 94.00 TRANSAMINASES INCREASED | 11 0.11 94.11 TRANSFUSION | 1 0.01 94.12 TRANSIENT ISCHAEMIC ATTACK | 7 0.07 94.19 TRANSITIONAL CELL CARCINOMA | 1 0.01 94.20 TRANSMISSION OF AN INFECTIOUS AGENT V.. | 1 0.01 94.21 TRANSMISSION OF DRUG VIA SEMEN | 7 0.07 94.28 TRANSPLANT REJECTION | 1 0.01 94.29 TRANSPOSITION OF THE GREAT VESSELS | 1 0.01 94.30 TRAUMATIC BRAIN INJURY | 1 0.01 94.31 TREATMENT FAILURE | 1 0.01 94.32 TREATMENT NONCOMPLIANCE | 9 0.09 94.41 TREMOR | 34 0.34 94.75 TREMOR NEONATAL | 1 0.01 94.76 TRICUSPID VALVE INCOMPETENCE | 3 0.03 94.79 TRIGEMINAL NEURALGIA | 2 0.02 94.81 TRIGGER FINGER | 1 0.01 94.82 TUBERCULOSIS | 2 0.02 94.84 TUBERCULOUS PLEURISY | 2 0.02 94.86 TUMOUR EXCISION | 1 0.01 94.87 TUMOUR HAEMORRHAGE | 2 0.02 94.89 TUMOUR MARKER INCREASED | 1 0.01 94.90 TUMOUR NECROSIS | 1 0.01 94.91 TYPE 1 DIABETES MELLITUS | 1 0.01 94.92 TYPE 2 DIABETES MELLITUS | 6 0.06 94.98 ULCER | 2 0.02 95.00 ULTRASOUND ABDOMEN ABNORMAL | 1 0.01 95.01 UMBILICAL CORD AROUND NECK | 1 0.01 95.02 UNDERDOSE | 1 0.01 95.03 UNEVALUABLE EVENT | 11 0.11 95.14 UNINTENDED PREGNANCY | 5 0.05 95.19 UNRESPONSIVE TO STIMULI | 4 0.04 95.23 UPPER EXTREMITY MASS | 1 0.01 95.24 UPPER LIMB FRACTURE | 1 0.01 95.25 UPPER RESPIRATORY TRACT INFECTION | 1 0.01 95.26 URETERIC DILATATION | 1 0.01 95.27 URETERIC OBSTRUCTION | 2 0.02 95.29 URETHRAL STENOSIS | 1 0.01 95.30 URGE INCONTINENCE | 1 0.01 95.31 URINARY BLADDER HAEMORRHAGE | 1 0.01 95.32 URINARY INCONTINENCE | 6 0.06 95.38 URINARY RETENTION | 4 0.04 95.42 URINARY SEDIMENT PRESENT | 1 0.01 95.43 URINARY TRACT INFECTION | 14 0.14 95.57 URINARY TRACT INFECTION ENTEROCOCCAL | 1 0.01 95.58 URINE ANALYSIS ABNORMAL | 3 0.03 95.61 URINE FLOW DECREASED | 2 0.02 95.63 URINE ODOUR ABNORMAL | 2 0.02 95.65 URINE OUTPUT DECREASED | 1 0.01 95.66 UROGENITAL HAEMORRHAGE | 1 0.01 95.67 UROSEPSIS | 3 0.03 95.70 URTICARIA | 38 0.38 96.08 UTERINE CANCER | 1 0.01 96.09 UTERINE DISORDER | 2 0.02 96.11 UTERINE ENLARGEMENT | 1 0.01 96.12 UTERINE HAEMORRHAGE | 1 0.01 96.13 UTERINE LEIOMYOMA | 2 0.02 96.15 UTERINE RUPTURE | 5 0.05 96.20 UVEITIS | 2 0.02 96.22 VAGINAL HAEMORRHAGE | 8 0.08 96.30 VAGINAL INFECTION | 1 0.01 96.31 VAGINAL LESION | 1 0.01 96.32 VAGINAL NEOPLASM | 1 0.01 96.33 VARICELLA | 1 0.01 96.34 VARICES OESOPHAGEAL | 1 0.01 96.35 VASCULAR GRAFT | 1 0.01 96.36 VASCULAR GRAFT OCCLUSION | 1 0.01 96.37 VASCULITIS | 5 0.05 96.42 VASOCONSTRICTION | 1 0.01 96.43 VENA CAVA THROMBOSIS | 1 0.01 96.44 VENOOCCLUSIVE DISEASE | 2 0.02 96.46 VENOOCCLUSIVE LIVER DISEASE | 1 0.01 96.47 VENOUS THROMBOSIS LIMB | 1 0.01 96.48 VENTRICULAR DYSFUNCTION | 2 0.02 96.50 VENTRICULAR EXTRASYSTOLES | 2 0.02 96.52 VENTRICULAR FIBRILLATION | 2 0.02 96.54 VENTRICULAR FLUTTER | 1 0.01 96.55 VENTRICULAR HYPERTROPHY | 2 0.02 96.57 VENTRICULAR HYPOPLASIA | 1 0.01 96.58 VENTRICULAR SEPTAL DEFECT | 8 0.08 96.66 VENTRICULAR TACHYCARDIA | 7 0.07 96.73 VERBAL ABUSE | 1 0.01 96.74 VERTIGO | 9 0.09 96.83 VIOLENCE-RELATED SYMPTOM | 2 0.02 96.85 VIRAL INFECTION | 5 0.05 96.90 VIRAL LOAD INCREASED | 1 0.01 96.91 VIRAL PHARYNGITIS | 1 0.01 96.92 VIRAL UPPER RESPIRATORY TRACT INFECTION | 1 0.01 96.93 VISION BLURRED | 27 0.27 97.20 VISUAL ACUITY REDUCED | 9 0.09 97.29 VISUAL DISTURBANCE | 16 0.16 97.45 VISUAL FIELD TESTS ABNORMAL | 1 0.01 97.46 VITAMIN D DECREASED | 1 0.01 97.47 VITAMIN D DEFICIENCY | 1 0.01 97.48 VITREOUS DETACHMENT | 2 0.02 97.50 VITREOUS FLOATERS | 1 0.01 97.51 VOCAL CORD PARALYSIS | 1 0.01 97.52 VOMITING | 91 0.91 98.43 VULVOVAGINAL BURNING SENSATION | 1 0.01 98.44 VULVOVAGINAL MYCOTIC INFECTION | 1 0.01 98.45 WAIST CIRCUMFERENCE INCREASED | 1 0.01 98.46 WALKING AID USER | 1 0.01 98.47 WEIGHT DECREASED | 52 0.52 98.99 WEIGHT FLUCTUATION | 1 0.01 99.00 WEIGHT INCREASED | 33 0.33 99.33 WHEEZING | 6 0.06 99.39 WHIPPLE'S DISEASE | 1 0.01 99.40 WHITE BLOOD CELL COUNT ABNORMAL | 1 0.01 99.41 WHITE BLOOD CELL COUNT DECREASED | 14 0.14 99.55 WHITE BLOOD CELL COUNT INCREASED | 11 0.11 99.66 WISDOM TEETH REMOVAL | 1 0.01 99.67 WITHDRAWAL BLEED | 2 0.02 99.69 WITHDRAWAL BLEEDING IRREGULAR | 1 0.01 99.70 WITHDRAWAL SYNDROME | 6 0.06 99.76 WOLFF-PARKINSON-WHITE SYNDROME | 1 0.01 99.77 WOUND | 1 0.01 99.78 WOUND ABSCESS | 1 0.01 99.79 WOUND DRAINAGE | 1 0.01 99.80 WOUND HAEMORRHAGE | 1 0.01 99.81 WOUND INFECTION | 1 0.01 99.82 WOUND INFECTION STAPHYLOCOCCAL | 2 0.02 99.84 WRIST FRACTURE | 2 0.02 99.86 WRONG TECHNIQUE IN DRUG USAGE PROCESS | 12 0.12 99.98 XEROSIS | 2 0.02 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015